{"DataElement":{"publicId":"6975011","version":"1","preferredName":"Concomitant Medication Use Indication Reason","preferredDefinition":"The condition, disease, symptom or disorder that the concomitant (non-study) medication/treatment/therapy was used to address or investigate (e.g., why the medication/treatment/therapy was taken or administered).","longName":"CMUSINRN","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6400412","version":"1","preferredName":"Concomitant Medication Domain Concomitant Medication Use Indication","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration._A signal which serves to indicate or point out the specific use cases for a particular concomitant medication.","longName":"4550855v1.0:6400410v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"4550855","version":"1","preferredName":"Concomitant Medication Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration.","longName":"C49568","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Medication Domain","conceptCode":"C49568","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to concomitant medication administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06047D53-A3ED-FF3E-E050-BB89AD430B5B","latestVersionIndicator":"Yes","beginDate":"2014-10-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-10-22","modifiedBy":"ONEDATA","dateModified":"2014-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6400410","version":"1","preferredName":"Concomitant Medication Use Indication","preferredDefinition":"A signal which serves to indicate or point out the specific use cases for a particular concomitant medication.","longName":"C83085","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Medication Use Indication","conceptCode":"C83085","definition":"A signal which serves to indicate or point out the specific use cases for a particular concomitant medication.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"736A09E0-DA91-5B35-E053-F662850AC5F4","latestVersionIndicator":"Yes","beginDate":"2018-08-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-08-14","modifiedBy":"ONEDATA","dateModified":"2018-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"736A09E0-DAA2-5B35-E053-F662850AC5F4","latestVersionIndicator":"Yes","beginDate":"2018-08-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-08-14","modifiedBy":"KUMMEROA","dateModified":"2021-06-09","changeDescription":"Elevated to Standard per governance approval by RA. 2021-6-9 ak. created for CDASH 8/14/18LS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2017187","version":"4","preferredName":"Concomitant Agent Concomitant Intervention or Procedure Reason","preferredDefinition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol._Accessory, accompanying especially in a subordinate or incidental way, occurring or existing during the same period of time._An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects._An explanation of the cause of some phenomenon or action.","longName":"CONCT_AGT_PROC_RSN","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Hyperuricemia","valueDescription":"Hyperuricemia","ValueMeaning":{"publicId":"2938161","version":"1","preferredName":"Hyperuricemia","longName":"2938161","preferredDefinition":"Elevated blood concentrations of uric acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperuricemia","conceptCode":"C3961","definition":"Elevated blood concentrations of uric acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"729930BE-653A-54CC-E040-BB89AD431E6D","latestVersionIndicator":"Yes","beginDate":"2009-09-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-09-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"729930BE-6553-54CC-E040-BB89AD431E6D","beginDate":"2009-09-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-09-02","modifiedBy":"ONEDATA","dateModified":"2009-09-02","deletedIndicator":"No"},{"value":"Xerosis","valueDescription":"XEROSIS","ValueMeaning":{"publicId":"2570824","version":"1","preferredName":"XEROSIS","longName":"2570824v1.00","preferredDefinition":"Abnormal body tissue dryness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Xerosis","conceptCode":"C199484","definition":"Abnormal body tissue dryness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E1B5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":"5/30/23 Added C199484 per cleanup activities for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D103-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Venous Thrombosis","valueDescription":"VENOUS THROMBOSIS","ValueMeaning":{"publicId":"2570795","version":"1","preferredName":"VENOUS THROMBOSIS","longName":"2570795v1.00","preferredDefinition":"The formation of a blood clot (thrombus) in the lumen of a vein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Venous Thrombosis","conceptCode":"C99107","definition":"The formation of a blood clot (thrombus) in the lumen of a vein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E198-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C99107 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D119-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Vasodilitation (Flush)","valueDescription":"Vasodilitation (Flush)","ValueMeaning":{"publicId":"2757852","version":"1","preferredName":"Vasodilitation (Flush)","longName":"2757852v1.00","preferredDefinition":"Vasodilation involves widening of a blood vessel lumen due to smooth muscle relaxation in the vessel wall and leads to increased blood flow._Reddening of the skin from a transient increase in blood flow.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vasodilation","conceptCode":"C40867","definition":"Vasodilation involves widening of a blood vessel lumen due to smooth muscle relaxation in the vessel wall and leads to increased blood flow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Flushing","conceptCode":"C26775","definition":"Reddening of the skin from a transient increase in blood flow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D126-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"CLOHNES","dateModified":"2023-06-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D13F-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Vascular Access","valueDescription":"Vascular Access","ValueMeaning":{"publicId":"2757853","version":"1","preferredName":"Vascular Access","longName":"2757853v1.00","preferredDefinition":"Relating to or containing blood vessels._The right to obtain or make use of or take advantage of something (as services or membership); the right to enter.  Also, an act or means of approaching.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vascular","conceptCode":"C13311","definition":"Relating to or containing blood vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Access","conceptCode":"C25396","definition":"The right to obtain or make use of or take advantage of something (as services or membership); the right to enter.  Also, an act or means of approaching.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D14B-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"CLOHNES","dateModified":"2023-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D164-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Vaginal Dryness","valueDescription":"Dryness of the vagina","ValueMeaning":{"publicId":"2757854","version":"1","preferredName":"Dryness of the vagina","longName":"2757854v1.00","preferredDefinition":"An uncomfortable feeling of itching and burning in the vaginal opening resulting from inadequate vaginal lubrication. It is commonly seen during and after menopause, childbirth, or stressful conditions. It results in painful intercourse.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal Dryness","conceptCode":"C78699","definition":"An uncomfortable feeling of itching and burning in the vaginal opening resulting from inadequate vaginal lubrication. It is commonly seen during and after menopause, childbirth, or stressful conditions. It results in painful intercourse.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D170-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C78699 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D189-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Urinary","valueDescription":"Urinary Urinary","ValueMeaning":{"publicId":"2757855","version":"1","preferredName":"Urinary Urinary","longName":"2757855","preferredDefinition":"Having to do with urine or the organs of the body that produce and get rid of urine.: Having to do with urine or the organs of the body that produce and get rid of urine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urinary","conceptCode":"C25711","definition":"Urinary; of or relating to urine, of or relating to the urinary system, or of or relating to the function or production or secretion of urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Urinary","conceptCode":"C25711","definition":"Urinary; of or relating to urine, of or relating to the urinary system, or of or relating to the function or production or secretion of urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D198-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D1B1-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Tremors","valueDescription":"Tremors","ValueMeaning":{"publicId":"2757856","version":"1","preferredName":"Tremors","longName":"2757856v1.00","preferredDefinition":"The shaking movement of the whole body or just a certain part of it, often caused by problems of the neurons responsible for muscle action.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tremor","conceptCode":"C38038","definition":"The shaking movement of the whole body or just a certain part of it, often caused by problems of the neurons responsible for muscle action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D1BD-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C38038 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D1D6-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Stomach Cramps","valueDescription":"Stomach Cramps","ValueMeaning":{"publicId":"2757857","version":"1","preferredName":"Stomach Cramps","longName":"2757857v1.00","preferredDefinition":"An involuntary muscular contraction in the stomach. Often, this cramp is spasmodic and can be uncomfortable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stomach Cramp","conceptCode":"C102529","definition":"An involuntary muscular contraction in the stomach. Often, this cramp is spasmodic and can be uncomfortable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D1E2-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C102529 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D1FB-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Rigors","valueDescription":"Rigors and shaking","ValueMeaning":{"publicId":"2757858","version":"1","preferredName":"Rigors and shaking","longName":"2757858v1.00","preferredDefinition":"Severe chills accompanied by vigorous shaking.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rigor","conceptCode":"C111658","definition":"Severe chills accompanied by vigorous shaking.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D207-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D220-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Restlessness","valueDescription":"RESTLESSNESS","ValueMeaning":{"publicId":"2570631","version":"1","preferredName":"RESTLESSNESS","longName":"2570631v1.00","preferredDefinition":"An inability to rest, relax, or be still.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Restlessness","conceptCode":"C74533","definition":"An inability to rest, relax, or be still.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E0F4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C74533 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D235-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Restless Leg Syndrome","valueDescription":"Restless Leg Syndrome","ValueMeaning":{"publicId":"2757859","version":"1","preferredName":"Restless Leg Syndrome","longName":"2757859v1.00","preferredDefinition":"A condition that occurs while resting or lying in bed; it is characterized by an irresistible urgency to move the legs to obtain relief from a strange and uncomfortable sensation in the legs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Restless Leg Syndrome","conceptCode":"C84501","definition":"A condition that occurs while resting or lying in bed; it is characterized by an irresistible urgency to move the legs to obtain relief from a strange and uncomfortable sensation in the legs.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D242-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C84501 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D25B-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Respiratory Distress/Dyspnea","valueDescription":"Respiratory Distress Dyspnea","ValueMeaning":{"publicId":"2757860","version":"1","preferredName":"Respiratory Distress Dyspnea","longName":"2757860v1.00","preferredDefinition":"A pathological increase in the effort and frequency of breathing movements._An uncomfortable sensation of difficulty breathing. It may present as an acute or chronic sign of an underlying respiratory or heart disorder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Respiratory Distress","conceptCode":"C27165","definition":"A pathological increase in the effort and frequency of breathing movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dyspnea","conceptCode":"C2998","definition":"An uncomfortable sensation of difficulty breathing. It may present as an acute or chronic sign of an underlying respiratory or heart disorder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D26A-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D283-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Replacement","valueDescription":"Replacement","ValueMeaning":{"publicId":"2570629","version":"1","preferredName":"Replacement","longName":"2570629","preferredDefinition":"The act of removing one thing and putting another thing in its place.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Replacement","conceptCode":"C53610","definition":"The act of removing one thing and putting another thing in its place.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E0F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"REEVESD","dateModified":"2014-03-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D298-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Renal/Urinary","valueDescription":"Renal Urinary","ValueMeaning":{"publicId":"2757861","version":"1","preferredName":"Renal Urinary","longName":"2757861","preferredDefinition":"Of or pertaining to the kidney.: Having to do with urine or the organs of the body that produce and get rid of urine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal","conceptCode":"C25225","definition":"Of or pertaining to the kidney.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Urinary","conceptCode":"C25711","definition":"Urinary; of or relating to urine, of or relating to the urinary system, or of or relating to the function or production or secretion of urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D2A8-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D2C1-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Rectal Bleeding","valueDescription":"Rectal bleeding","ValueMeaning":{"publicId":"2562743","version":"1","preferredName":"Rectal bleeding","longName":"2562743v1.00","preferredDefinition":"Of or pertaining to the rectum._The flow of blood from a ruptured blood vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rectal","conceptCode":"C25224","definition":"Of or pertaining to the rectum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C224-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D2D6-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Pulmonary Embolus","valueDescription":"Pulmonary Embolus","ValueMeaning":{"publicId":"2757862","version":"1","preferredName":"Pulmonary Embolus","longName":"2757862v1.00","preferredDefinition":"Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract._A mass of clotted blood or other formed elements, such as bubbles of air, calcium fragments, etc. brought by the blood from another vessel and forced into a smaller one, thus obstructing the circulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary","conceptCode":"C13304","definition":"Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Embolus","conceptCode":"C50547","definition":"A mass of clotted blood or other formed elements, such as bubbles of air, calcium fragments, etc. brought by the blood from another vessel and forced into a smaller one, thus obstructing the circulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D2E3-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":"5/26/23 Added concepts to VM per cleanup activities for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D2FC-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Preprocedure/Diagnostic Testing","valueDescription":"Before a Procedure or Diagnostic Testing","ValueMeaning":{"publicId":"2757863","version":"1","preferredName":"Before a Procedure or Diagnostic Testing","longName":"2757863v1.00","preferredDefinition":"Earlier in time or order._An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Characteristic or indicative of a condition._A procedure for critical evaluation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Intervention or Procedure","conceptCode":"C25218","definition":"An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diagnostic","conceptCode":"C25482","definition":"Characteristic or indicative of a condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Testing","conceptCode":"C15336","definition":"A procedure for critical evaluation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D308-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"CLOHNES","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":"5/30/23 Added concepts per cleanup activities for CCTG, added prior def as alt def cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D321-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Prechemotherapy","valueDescription":"BEFORE CHEMOTHERAPY","ValueMeaning":{"publicId":"2582131","version":"1","preferredName":"BEFORE CHEMOTHERAPY","longName":"2582131v1.00","preferredDefinition":"Earlier in time or order._The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0DE0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-22","endDate":null,"createdBy":"PWEST","dateCreated":"2006-11-22","modifiedBy":"CLOHNES","dateModified":"2023-06-07","changeDescription":null,"administrativeNotes":"6/7/23 added concepts for VM per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D336-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"PostTreatment","valueDescription":"After Treatment completion","ValueMeaning":{"publicId":"2757864","version":"1","preferredName":"After Treatment completion","longName":"2757864v1.00","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D343-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"CLOHNES","dateModified":"2023-06-07","changeDescription":null,"administrativeNotes":"6/7/23 added concepts to VM per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D35C-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"PreTreatment","valueDescription":"Before Treatment","ValueMeaning":{"publicId":"2757865","version":"1","preferredName":"Before Treatment","longName":"2757865v1.00","preferredDefinition":"Any relevant actions that were performed or occurred prior to a specific treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pretreatment","conceptCode":"C103339","definition":"Any relevant actions that were performed or occurred prior to a specific treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D368-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D381-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Post Traumatic Stress Disorder","valueDescription":"Post Traumatic Stress Disorder","ValueMeaning":{"publicId":"2757866","version":"1","preferredName":"Post Traumatic Stress Disorder","longName":"2757866v1.00","preferredDefinition":"An anxiety disorder precipitated by an experience of intense fear or horror while exposed to a traumatic (especially life-threatening) event. The disorder is characterized by intrusive recurring thoughts or images of the traumatic event; avoidance of anything associated with the event; a state of hyperarousal and diminished emotional responsiveness. These symptoms are present for at least one month and the disorder is usually long-term.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post-Traumatic Stress Disorder","conceptCode":"C3389","definition":"An anxiety disorder precipitated by an experience of intense fear or horror while exposed to a traumatic (especially life-threatening) event. The disorder is characterized by intrusive recurring thoughts or images of the traumatic event; avoidance of anything associated with the event; a state of hyperarousal and diminished emotional responsiveness. These symptoms are present for at least one month and the disorder is usually long-term.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D38D-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D3A6-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Port Occlusion","valueDescription":"Occlusion within Medical Device","ValueMeaning":{"publicId":"2757868","version":"1","preferredName":"Occlusion within Medical Device","longName":"2757868","preferredDefinition":"Issue associated with obstruction, closure or blockage of device opening, pipe, tube or another narrow comprising part.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occlusion within Medical Device","conceptCode":"C62896","definition":"Issue associated with an obstruction or blockage within any of the device components (e.g. tube, opening, pipe) that results in a restriction of flow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D3B5-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D3CE-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Pneumonitis","valueDescription":"Pneumonia","ValueMeaning":{"publicId":"2559821","version":"1","preferredName":"Pneumonia","longName":"2559821","preferredDefinition":"An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pneumonia","conceptCode":"C3333","definition":"An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6BA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2020-11-19","changeDescription":"11.19.2020 Updated concept annotation and long name to current NCIt . mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D3E3-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Pleural Effusion","valueDescription":"Pleural Effusion","ValueMeaning":{"publicId":"2757869","version":"1","preferredName":"Pleural Effusion","longName":"2757869","preferredDefinition":"Increased amounts of fluid within the pleural cavity containing no malignant cells","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pleural Effusion","conceptCode":"C3331","definition":"Increased amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough, and chest pain. It is usually caused by lung infections, congestive heart failure, pleural and lung tumors, connective tissue disorders, and trauma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D3F0-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D409-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Prophylaxis","valueDescription":"Preventive Intervention","ValueMeaning":{"publicId":"2757870","version":"1","preferredName":"Preventive Intervention","longName":"2757870","preferredDefinition":"An attempt to prevent disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D415-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D42E-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Pruritus","valueDescription":"Pruritus","ValueMeaning":{"publicId":"2757871","version":"1","preferredName":"Pruritus","longName":"2757871","preferredDefinition":"An intense itching sensation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pruritus","conceptCode":"C3344","definition":"An intense itching sensation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D43A-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D453-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Pseudogout","valueDescription":"Pseudogout","ValueMeaning":{"publicId":"2757873","version":"1","preferredName":"Pseudogout","longName":"2757873v1.00","preferredDefinition":"An acute episode of pain, swelling, and redness, sometimes associated with fever. It is caused by the deposition of calcium pyrophosphate crystals in the joints.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pseudogout","conceptCode":"C34955","definition":"An acute episode of pain, swelling, and redness, sometimes associated with fever. It is caused by the deposition of calcium pyrophosphate crystals in the joints.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D462-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D47B-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Psoriasis","valueDescription":"Psoriasis","ValueMeaning":{"publicId":"2567418","version":"1","preferredName":"Psoriasis","longName":"2567418","preferredDefinition":"A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Psoriasis","conceptCode":"C3346","definition":"An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D467-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D487-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Rash","valueDescription":"Skin Rash","ValueMeaning":{"publicId":"2578055","version":"1","preferredName":"Skin Rash","longName":"2578055","preferredDefinition":"Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Rash","conceptCode":"C39594","definition":"Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDF4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-01","modifiedBy":"COOPERM","dateModified":"2017-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D498-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Reflux","valueDescription":"Reflux","ValueMeaning":{"publicId":"2570652","version":"1","preferredName":"Reflux","longName":"2570652v1.00","preferredDefinition":"The backward flow of stomach acid contents into the esophagus (the tube that connects the mouth to the stomach).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastroesophageal Reflux","conceptCode":"C92560","definition":"The backward flow of stomach acid contents into the esophagus (the tube that connects the mouth to the stomach).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E109-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D4A4-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Rhinorrhea","valueDescription":"Rhinorrhea","ValueMeaning":{"publicId":"2757875","version":"1","preferredName":"Rhinorrhea","longName":"2757875","preferredDefinition":"A discharge of fluid from the nose.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rhinorrhea","conceptCode":"C54282","definition":"A discharge of fluid from the nose.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D4B4-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"TAYLORT","dateModified":"2020-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D4CD-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Scabies","valueDescription":"Scabies","ValueMeaning":{"publicId":"2575973","version":"1","preferredName":"Scabies","longName":"2575973v1.00","preferredDefinition":"A contagious skin infection that is caused by the burrowing parasitic mite, Sarcoptes scabiei, and is characterized by intense itching and small, raised red spots in the area of the mite burrows.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Scabies","conceptCode":"C34998","definition":"A contagious skin infection that is caused by the burrowing parasitic mite, Sarcoptes scabiei, and is characterized by intense itching and small, raised red spots in the area of the mite burrows.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F5D2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-08-24","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C34998 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D4D9-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Seizures","valueDescription":"Seizure","ValueMeaning":{"publicId":"2569494","version":"1","preferredName":"Seizure","longName":"2569494","preferredDefinition":"the most dramatic type of seizure, characterized by tonic and clonic contraction of most skeletal muscles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Seizure","conceptCode":"C2962","definition":"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC83-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-10","modifiedBy":"REEVESD","dateModified":"2008-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D4F3-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Sinusitis","valueDescription":"Sinusitis","ValueMeaning":{"publicId":"2757877","version":"1","preferredName":"Sinusitis","longName":"2757877","preferredDefinition":"An inflammatory process of the mucous membranes of the paranasal sinuses that occurs in three stages: acute, subacute, and chronic. Sinusitis results from any condition causing ostial obstruction or from pathophysiologic changes in the mucociliary transport mechanism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinusitis","conceptCode":"C35024","definition":"An acute or chronic inflammatory process affecting the mucous membranes of any sinus cavity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D502-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D51B-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Skin Irritation","valueDescription":"Skin Irritation","ValueMeaning":{"publicId":"2757878","version":"1","preferredName":"Skin Irritation","longName":"2757878","preferredDefinition":"A mild inflammatory dermal tissue reaction; it can be caused by physical contact with an irritant or can be a local response to a systemic trigger. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Irritation","conceptCode":"C50743","definition":"A mild inflammatory dermal tissue reaction; it can be caused by physical contact with an irritant or can be a local response to a systemic trigger.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D529-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D542-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Sleep","valueDescription":"Sleep","ValueMeaning":{"publicId":"2757879","version":"1","preferredName":"Sleep","longName":"2757879","preferredDefinition":"A natural and periodic state of rest during which  consciousness of the world is suspended.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sleep","conceptCode":"C73425","definition":"A natural and periodic state of rest during which consciousness of the world is suspended.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D550-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D569-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Sleep Apnea","valueDescription":"Sleep Apnea","ValueMeaning":{"publicId":"2757881","version":"1","preferredName":"Sleep Apnea","longName":"2757881","preferredDefinition":"Cessation of breathing for short periods during sleep. It is classified as obstructive, central, or mixed obstructive-central. It can occur at any age but it is more frequent in people over forty. Risk factors include male sex and obesity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sleep Apnea","conceptCode":"C26884","definition":"Cessation of breathing for short periods during sleep. It is classified as obstructive, central, or mixed obstructive-central. It can occur at any age but it is more frequent in people over forty. Risk factors include male sex and obesity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D578-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D591-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Smoking Cessation","valueDescription":"Smoking Cessation","ValueMeaning":{"publicId":"2757882","version":"1","preferredName":"Smoking Cessation","longName":"2757882","preferredDefinition":"Discontinuation of the habit of smoking.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Smoking Cessation","conceptCode":"C17427","definition":"Discontinuation of the habit of smoking.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D59F-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D5B8-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Stomatitis","valueDescription":"Stomatitis","ValueMeaning":{"publicId":"2562567","version":"1","preferredName":"Stomatitis","longName":"2562567v1.00","preferredDefinition":"Inflammation of the oral mucosa due to local or systemic factors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stomatitis","conceptCode":"C26887","definition":"Inflammation of the oral mucosa due to local or systemic factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C174-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-04","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-04","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D5C4-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Supplement","valueDescription":"Supplement","ValueMeaning":{"publicId":"2757883","version":"1","preferredName":"Supplement","longName":"2757883","preferredDefinition":"Something added to complete a thing, make up for a deficiency, or extend or strengthen the whole; serving to complete or make an addition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Supplement","conceptCode":"C68641","definition":"Something added to complete a thing, make up for a deficiency, or extend or strengthen the whole; serving to complete or make an addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D5D3-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D5EC-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Thrombocytopenia","valueDescription":"Thrombocytopenia","ValueMeaning":{"publicId":"2569502","version":"1","preferredName":"Thrombocytopenia","longName":"2569502v1.00","preferredDefinition":"A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombocytopenia","conceptCode":"C3408","definition":"A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC8B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-10","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C3408 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D5F8-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Thrombus","valueDescription":"Blood Clot","ValueMeaning":{"publicId":"2757885","version":"1","preferredName":"Blood Clot","longName":"2757885","preferredDefinition":"An aggregation of blood factors, primarily platelets and fibrin with entrapment of cellular elements, frequently causing vascular obstruction at the point of its formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blood Clot","conceptCode":"C27083","definition":"An aggregation of blood factors, primarily platelets and fibrin with entrapment of cellular elements, frequently causing vascular obstruction at the point of its formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D608-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D621-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Thrush","valueDescription":"Oral Candidiasis","ValueMeaning":{"publicId":"2757886","version":"1","preferredName":"Oral Candidiasis","longName":"2757886","preferredDefinition":"Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Candidiasis","conceptCode":"C28137","definition":"Infection of the mucosal lining of the mouth with the fungus Candida albicans.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D62F-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D648-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Urticaria","valueDescription":"Urticaria","ValueMeaning":{"publicId":"2739313","version":"1","preferredName":"Urticaria","longName":"2739313","preferredDefinition":"A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urticaria","conceptCode":"C3432","definition":"A transient, itchy skin eruption characterized by wheals with pale interiors and red margins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A4E258C-71CC-3C04-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D65D-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Vertigo","valueDescription":"Vertigo (Dizziness)","ValueMeaning":{"publicId":"2571858","version":"1","preferredName":"Vertigo (Dizziness)","longName":"2571858v1.00","preferredDefinition":"A feeling of movement, a sensation as if the external world were revolving around the patient (objective vertigo) or as if he himself were revolving in space (subjective vertigo). Vertigo is medically distinct from dizziness, lightheadedness, and unsteadiness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vertigo","conceptCode":"C38057","definition":"A feeling of movement, a sensation as if the external world were revolving around the patient (objective vertigo) or as if he himself were revolving in space (subjective vertigo). Vertigo is medically distinct from dizziness, lightheadedness, and unsteadiness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E5BF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-09-13","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C38057 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D669-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Vitamins","valueDescription":"Vitamin","ValueMeaning":{"publicId":"2757888","version":"1","preferredName":"Vitamin","longName":"2757888","preferredDefinition":"Key nutrients that the body needs in small amounts to grow and stay strong.  Examples are vitamins A, C, and E.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vitamin","conceptCode":"C944","definition":"A group of organic food substances found in animals and plants in small quantities. They must be supplied in diet or dietary supplement and are essential for normal metabolism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D679-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D692-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Vomiting","valueDescription":"Vomiting","ValueMeaning":{"publicId":"2739310","version":"1","preferredName":"Vomiting","longName":"2739310","preferredDefinition":"Vomiting; the reflex act of ejecting the contents of the stomach through the mouth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vomiting","conceptCode":"C3442","definition":"Forceful ejection of the contents of the stomach through the mouth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A4E258C-712B-3C04-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D69E-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Weight Gain","valueDescription":"Weight Gain","ValueMeaning":{"publicId":"2573190","version":"1","preferredName":"Weight Gain","longName":"2573190v1.00","preferredDefinition":"An increase in total body weight.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Weight Gain","conceptCode":"C62754","definition":"An increase in total body weight.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EAF3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-18","modifiedBy":"CLOHNES","dateModified":"2023-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D6AA-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Weight Loss","valueDescription":"Weight Loss","ValueMeaning":{"publicId":"2757889","version":"1","preferredName":"Weight Loss","longName":"2757889","preferredDefinition":"A reduction in overall body mass.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Weight Loss","conceptCode":"C3445","definition":"A reduction in total body weight.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D6B6-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"KUMMEROA","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D6CF-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Xerostomia","valueDescription":"Dry Mouth","ValueMeaning":{"publicId":"2757890","version":"1","preferredName":"Dry Mouth","longName":"2757890","preferredDefinition":"dryness of the mouth due to salivary gland secretion dysfunction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Xerostomia","conceptCode":"C26917","definition":"Dryness of the oral mucosa secondary to a decrease in saliva production, or a change in saliva composition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D6DB-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4F3F8B84-D6F4-3BC8-E044-0003BA3F9857","beginDate":"2008-06-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"REEVESD","dateModified":"2008-06-09","deletedIndicator":"No"},{"value":"Hormonal Manipulation","valueDescription":"HORMONAL MANIPULATION","ValueMeaning":{"publicId":"2570330","version":"1","preferredName":"HORMONAL MANIPULATION","longName":"2570330v1.00","preferredDefinition":"Relating to hormones._Move, treat, or operate with the hands or by mechanical means, especially in a skillful manner.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormonal","conceptCode":"C25528","definition":"Relating to hormones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Manipulation","conceptCode":"C48310","definition":"Move, treat, or operate with the hands or by mechanical means, especially in a skillful manner.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DFC7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC7CDA8-4250-5ECE-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hiatal hernia","valueDescription":"Hiatal hernia","ValueMeaning":{"publicId":"2580534","version":"1","preferredName":"Hiatal hernia","longName":"2580534v1.00","preferredDefinition":"Herniation of the upper part of the stomach through the diaphragm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hiatal Hernia","conceptCode":"C98945","definition":"Herniation of the upper part of the stomach through the diaphragm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-07A3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-17","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-08-17","modifiedBy":"CLOHNES","dateModified":"2023-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC7CDA8-425D-5ECE-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hepatic Lab abnormality","valueDescription":"Laboratory Hepatic Abnormality","ValueMeaning":{"publicId":"2751373","version":"1","preferredName":"Laboratory Hepatic Abnormality","longName":"2751373","preferredDefinition":"Laboratory; a workplace for the conduct of scientific research.: Refers to the liver.: A condition that differs from the usual physical or mental state.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory","conceptCode":"C37984","definition":"A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hepatic","conceptCode":"C13308","definition":"Pertaining to, affecting, or associated with the liver.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Abnormality","conceptCode":"C9440","definition":"A condition that differs from the usual physical or mental state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC7CDA8-426E-5ECE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC7CDA8-4287-5ECE-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Heparin Reversal","valueDescription":"Heparin Reversal","ValueMeaning":{"publicId":"2751374","version":"1","preferredName":"Heparin Reversal","longName":"2751374v1.00","preferredDefinition":"A sulfur-rich glycosaminoglycan with anticoagulant property. Heparin binds to antithrombin III to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors, such as factors IX, X, XI, and XII, thereby preventing the polymerization of fibrinogen to fibrin and the subsequent formation of clots._A change in something from one state to the opposite state.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Heparin","conceptCode":"C539","definition":"A sulfur-rich glycosaminoglycan with anticoagulant property. Heparin binds to antithrombin III to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors, such as factors IX, X, XI, and XII, thereby preventing the polymerization of fibrinogen to fibrin and the subsequent formation of clots.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reversal","conceptCode":"C125005","definition":"A change in something from one state to the opposite state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC7CDA8-4293-5ECE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":"5/26/23 Added concepts and made prior def a manually curated alt def per cleanup activities per CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC7CDA8-42AC-5ECE-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hemolytic Urem Syndrome","valueDescription":"Hemolytic Uremic Syndrome symptoms","ValueMeaning":{"publicId":"2751375","version":"1","preferredName":"Hemolytic Uremic Syndrome symptoms","longName":"2751375v1.00","preferredDefinition":"Acute kidney injury associated with microangiopathic hemolytic anemia and thrombocytopenia._Exhibiting the symptoms of a particular disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemolytic Uremic Syndrome","conceptCode":"C75545","definition":"Acute kidney injury associated with microangiopathic hemolytic anemia and thrombocytopenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Symptomatic","conceptCode":"C25269","definition":"Exhibiting the symptoms of a particular disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC7CDA8-42B8-5ECE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":"5/26/23 Added concepts for VM, put former def as  alt def per cleanup activities per CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC7CDA8-42D1-5ECE-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Gastrointestinal distress","valueDescription":"Gastrointestinal distress","ValueMeaning":{"publicId":"2751376","version":"1","preferredName":"Gastrointestinal distress","longName":"2751376v1.00","preferredDefinition":"Pertaining to the stomach and intestines._A state of physiological or psychological stress that cannot be compensated for by normal adaptive measures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal","conceptCode":"C13359","definition":"Pertaining to the stomach and intestines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Distress","conceptCode":"C37942","definition":"A state of physiological or psychological stress that cannot be compensated for by normal adaptive measures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC7CDA8-42DD-5ECE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC7CDA8-42F6-5ECE-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"GI Decontamination","valueDescription":"Gastrointestinal Decontamination","ValueMeaning":{"publicId":"2751377","version":"1","preferredName":"Gastrointestinal Decontamination","longName":"2751377v1.00","preferredDefinition":"Pertaining to the stomach and intestines._To rid of contamination.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal","conceptCode":"C13359","definition":"Pertaining to the stomach and intestines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Decontamination","conceptCode":"C68769","definition":"To rid of contamination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC7CDA8-4302-5ECE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC7CDA8-431B-5ECE-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Fluid Retention","valueDescription":"FLUID RETENTION","ValueMeaning":{"publicId":"2570290","version":"1","preferredName":"FLUID RETENTION","longName":"2570290v1.00","preferredDefinition":"A continuous amorphous substance that tends to flow and to conform to the outline of its container (i.e., a liquid or a gas).  Also used as an adjective to describe something with properties like that of a fluid._The condition of remaining in a place or position or of holding within.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluid","conceptCode":"C25278","definition":"A continuous amorphous substance that tends to flow and to conform to the outline of its container (i.e., a liquid or a gas).  Also used as an adjective to describe something with properties like that of a fluid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Retention","conceptCode":"C38016","definition":"The condition of remaining in a place or position or of holding within.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF9F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC7CDA8-4330-5ECE-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Fluid Overload","valueDescription":"Fluid Overload","ValueMeaning":{"publicId":"2751378","version":"1","preferredName":"Fluid Overload","longName":"2751378v1.00","preferredDefinition":"Too much fluid in the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypervolemia","conceptCode":"C50591","definition":"Fluid accumulation in tissues and body cavities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC7CDA8-433D-5ECE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC7CDA8-4356-5ECE-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Fever w/Low WBC","valueDescription":"Fever Leukocyte","ValueMeaning":{"publicId":"2751379","version":"1","preferredName":"Fever Leukocyte","longName":"2751379","preferredDefinition":"Fever, also known as pyrexia, is the elevation of the body's temperature above the upper limit of normal, usually taken as 37.7 degrees C.  Most fevers are caused by infections and almost all infectious diseases cause fever. (Wikipedia): White blood cells. These include granular leukocytes (BASOPHILS, EOSINOPHILS, and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fever","conceptCode":"C3038","definition":"Elevation of body temperature above normal due to inflammatory or immune responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Leukocyte","conceptCode":"C12529","definition":"Blood cells that are devoid of hemoglobin, capable of ameboid motion and phagocytosis, and act as the principal components of the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC7CDA8-4365-5ECE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC7CDA8-437E-5ECE-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Eye Redness","valueDescription":"Eye Redness","ValueMeaning":{"publicId":"2751380","version":"1","preferredName":"Eye Redness","longName":"2751380v1.00","preferredDefinition":"The prominence of the superficial vessels of the sclera or conjunctiva resulting in a red or pink appearance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eye Redness","conceptCode":"C118724","definition":"The prominence of the superficial vessels of the sclera or conjunctiva resulting in a red or pink appearance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC7CDA8-438A-5ECE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC7CDA8-43A3-5ECE-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Extrapyramidal","valueDescription":"Extrapyramidal symptoms","ValueMeaning":{"publicId":"2751381","version":"1","preferredName":"Extrapyramidal symptoms","longName":"2751381v1.00","preferredDefinition":"A movement disorder caused by defects in the basal ganglia. The clinical manifestations include changes in the muscle tone, dyskinesia, and akinesia. Causes include vascular disorders, degenerative disorders, and antipsychotic drugs._Subjective evidence of disease perceived by the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extrapyramidal Disorder","conceptCode":"C79593","definition":"A movement disorder caused by defects in the basal ganglia. The clinical manifestations include changes in the muscle tone, dyskinesia, and akinesia. Causes include vascular disorders, degenerative disorders, and antipsychotic drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC7CDA8-43AF-5ECE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC7CDA8-43C8-5ECE-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Dry Skin","valueDescription":"Dryness Skin","ValueMeaning":{"publicId":"2751384","version":"1","preferredName":"Dryness Skin","longName":"2751384","preferredDefinition":"Dryness; lacking moisture, or the feeling thereof.: 1. An organ and the enveloping membrane of the body; includes, in addition to the epidermis and dermis, all of the derivatives of the epidermis, e.g., hairs, nails, sudoriferous and sebaceous glands, and mammary glands. Subdivisions of the skin surround various body parts; as a whole, the skin constitutes the external surface of the body. 2. The rind, capsule, or covering of any body or part.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dryness","conceptCode":"C25489","definition":"The lack of natural or normal moisture.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Skin","conceptCode":"C12470","definition":"An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0834-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-084D-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hot Flashes","valueDescription":"Hot Flashes","ValueMeaning":{"publicId":"2751385","version":"1","preferredName":"Hot Flashes","longName":"2751385","preferredDefinition":"A sudden, temporary onset of body warmth, flushing, and sweating (often associated with menopause).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hot Flashes","conceptCode":"C3109","definition":"A temporary feeling of intense body warmth, flushing, sometimes accompanied by sweating. A common, symptom of menopause; other conditions that can produce hot flushes include antidepressants and drugs blocking the effect of estrogens, carcinoid tumors and a sensitivity to sulfites or other food additives.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-085A-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0873-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hypercalcemia","valueDescription":"Hypercalcemia","ValueMeaning":{"publicId":"2751386","version":"1","preferredName":"Hypercalcemia","longName":"2751386","preferredDefinition":"Abnormally high level of calcium in the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypercalcemia","conceptCode":"C3112","definition":"Abnormally high concentration of calcium in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-087F-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0898-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hypercholesterolemia","valueDescription":"Hypercholesterolemia","ValueMeaning":{"publicId":"2751387","version":"1","preferredName":"Hypercholesterolemia","longName":"2751387","preferredDefinition":"Hypercholesterolemia; the presence of an abnormal amount of cholesterol in the cells and plasma of the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypercholesterolemia","conceptCode":"C37967","definition":"A laboratory test result indicating an increased amount of cholesterol in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-08A4-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-08BD-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hyperglycemia","valueDescription":"Hyperglycemia","ValueMeaning":{"publicId":"2751388","version":"1","preferredName":"Hyperglycemia","longName":"2751388","preferredDefinition":"Abnormally high blood sugar.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperglycemia","conceptCode":"C26797","definition":"Abnormally high level of glucose in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-08C9-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-08E2-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hyperkalemia","valueDescription":"Hyperkalemia","ValueMeaning":{"publicId":"2751389","version":"1","preferredName":"Hyperkalemia","longName":"2751389","preferredDefinition":"Hyperkalemia; higher than normal levels of potassium in the circulating blood; associated with kidney failure or sometimes with the use of diuretic drugs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperkalemia","conceptCode":"C37968","definition":"Higher than normal levels of potassium in the circulating blood; associated with kidney failure or sometimes with the use of diuretic drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-08EE-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0907-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hyperlipidemia","valueDescription":"Hyperlipidemia","ValueMeaning":{"publicId":"2751390","version":"1","preferredName":"Hyperlipidemia","longName":"2751390","preferredDefinition":"An excess of lipids in the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperlipidemia","conceptCode":"C34707","definition":"Elevated levels of lipids in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0915-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-092E-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hyperparathyroidism","valueDescription":"Hyperparathyroidism","ValueMeaning":{"publicId":"2751392","version":"1","preferredName":"Hyperparathyroidism","longName":"2751392v1.00","preferredDefinition":"Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It may be primary or secondary; primary hyperparathyroidism is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones. Secondary hyperparathyroidism is caused by the chronic stimulation of the parathyroid glands in patients with chronic renal failure, rickets, and malabsorption syndromes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperparathyroidism","conceptCode":"C48259","definition":"Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It may be primary or secondary; primary hyperparathyroidism is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones. Secondary hyperparathyroidism is caused by the chronic stimulation of the parathyroid glands in patients with chronic renal failure, rickets, and malabsorption syndromes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-093D-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-05-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0956-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hypertension","valueDescription":"Hypertension","ValueMeaning":{"publicId":"2562555","version":"1","preferredName":"Hypertension","longName":"2562555","preferredDefinition":"Abnormally high blood pressure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertension","conceptCode":"C3117","definition":"Blood pressure that is abnormally high.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C168-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-04","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-04","modifiedBy":"ZHANGW","dateModified":"2008-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0962-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Keratitis sicca (Dry Eyes)","valueDescription":"Dry Eyes","ValueMeaning":{"publicId":"2751393","version":"1","preferredName":"Dry Eyes","longName":"2751393v1.00","preferredDefinition":"A syndrome characterized by dryness of the cornea and conjunctiva. It is usually caused by a deficiency in tear production. Symptoms include a feeling of burning eyes and a possible foreign body presence in the eye.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dry Eye Syndrome","conceptCode":"C34553","definition":"A syndrome characterized by dryness of the cornea and conjunctiva. It is usually caused by a deficiency in tear production. Symptoms include a feeling of burning eyes and a possible foreign body presence in the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-096F-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-06-07","changeDescription":null,"administrativeNotes":"6/7/23 Added concepts to VM per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0988-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Itching","valueDescription":"Itching sensation","ValueMeaning":{"publicId":"2751394","version":"1","preferredName":"Itching sensation","longName":"2751394v1.00","preferredDefinition":"An intense itching sensation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pruritus","conceptCode":"C3344","definition":"An intense itching sensation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0994-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-09AD-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Induce Sedation","valueDescription":"Sedation","ValueMeaning":{"publicId":"2751396","version":"1","preferredName":"Sedation","longName":"2751396","preferredDefinition":"The process of allaying nervous excitement or the state of being calmed. (Taber's)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sedation","conceptCode":"C21097","definition":"The process of allaying nervous excitement or the state of being calmed. (Taber's)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-09BC-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-09D5-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Indigestion","valueDescription":"Indigestion","ValueMeaning":{"publicId":"2570350","version":"1","preferredName":"Indigestion","longName":"2570350v1.00","preferredDefinition":"An uncomfortable, often painful feeling in the stomach, resulting from impaired digestion. Symptoms include burning stomach pain, bloating, heartburn, nausea, and vomiting. Causes include gastritis, gastric ulcer, gastroesophageal reflux disease, pancreatic disease, and gallbladder disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dyspepsia","conceptCode":"C26756","definition":"An uncomfortable, often painful feeling in the stomach, resulting from impaired digestion. Symptoms include burning stomach pain, bloating, heartburn, nausea, and vomiting. Causes include gastritis, gastric ulcer, gastroesophageal reflux disease, pancreatic disease, and gallbladder disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DFDB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-09E1-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hyperthyroidism","valueDescription":"Hyperthyroidism","ValueMeaning":{"publicId":"2751397","version":"1","preferredName":"Hyperthyroidism","longName":"2751397","preferredDefinition":"Excessive functional activity of the thyroid gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperthyroidism","conceptCode":"C3123","definition":"Overactivity of the thyroid gland resulting in overproduction of thyroid hormone and increased metabolic rate. Causes include diffuse hyperplasia of the thyroid gland (Graves' disease), single nodule in the thyroid gland, and thyroiditis. The symptoms are related to the increased metabolic rate and include weight loss, fatigue, heat intolerance, excessive sweating, diarrhea, tachycardia, insomnia, muscle weakness, and tremor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-09EE-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0A07-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hypoalbuminemia","valueDescription":"Hypoalbuminemia","ValueMeaning":{"publicId":"2751398","version":"1","preferredName":"Hypoalbuminemia","longName":"2751398","preferredDefinition":"Hypoalbuminemia; an abnormally low blood level of albumin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypoalbuminemia","conceptCode":"C37972","definition":"Concentration of serum albumin below normal limits for the age related normal range.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0A13-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0A2C-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hypocalcemia","valueDescription":"Hypocalcemia","ValueMeaning":{"publicId":"2751399","version":"1","preferredName":"Hypocalcemia","longName":"2751399","preferredDefinition":"Hypocalemia; lower than normal levels of calcium in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypocalcemia","conceptCode":"C37973","definition":"Lower than normal levels of calcium in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0A38-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0A51-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hypokalemia","valueDescription":"Hypokalemia","ValueMeaning":{"publicId":"2751400","version":"1","preferredName":"Hypokalemia","longName":"2751400","preferredDefinition":"Hypokalemia; lower than normal levels of potassium in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypokalemia","conceptCode":"C37974","definition":"Lower than normal levels of potassium in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0A5D-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0A76-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hypomagnesemia","valueDescription":"Hypomagnesemia","ValueMeaning":{"publicId":"2751401","version":"1","preferredName":"Hypomagnesemia","longName":"2751401","preferredDefinition":"Hypermagnesemia; lower than normal levels of magnesium in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypomagnesemia","conceptCode":"C37975","definition":"Lower than normal levels of magnesium in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0A82-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0A9B-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hypophosphatemia","valueDescription":"Hypophosphatemia","ValueMeaning":{"publicId":"2751402","version":"1","preferredName":"Hypophosphatemia","longName":"2751402","preferredDefinition":"Hypophosphatemia; lower than normal levels of phosphates in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypophosphatemia","conceptCode":"C37977","definition":"Lower than normal levels of phosphates in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0AA7-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0AC0-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hypotension","valueDescription":"Hypotension","ValueMeaning":{"publicId":"2562556","version":"1","preferredName":"Hypotension","longName":"2562556","preferredDefinition":"Abnormally low blood pressure seen in shock but not necessarily indicative of it. (Dorland, 28th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypotension","conceptCode":"C3128","definition":"Blood pressure that is abnormally low.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C169-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-04","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-04","modifiedBy":"ZHANGW","dateModified":"2008-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0ACC-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hypothyroidism","valueDescription":"Hypothyroidism","ValueMeaning":{"publicId":"2562672","version":"1","preferredName":"Hypothyroidism","longName":"2562672","preferredDefinition":"A condition in which the production of thyroid hormone by the thyroid gland is diminished. Signs and symptoms of hypothyroidism include low metabolic rate, tendency to weight gain, somnolence and sometimes myxedema. In the United States, the most common cause of hypothyroidism is Hashimoto's thyroiditis, an autoimmune disorder. SYN athyrea. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypothyroidism","conceptCode":"C26800","definition":"Abnormally low levels of thyroid hormone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1DD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"COOPERM","dateModified":"2008-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0AD8-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Hypoxia","valueDescription":"Hypoxia","ValueMeaning":{"publicId":"2562705","version":"1","preferredName":"Hypoxia","longName":"2562705","preferredDefinition":"reduction of oxygen supply to tissue below physiological level.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypoxia","conceptCode":"C3890","definition":"A decrease in the amount of oxygen in the body. Symptoms range from mild (impaired judgment, memory loss, impaired motor coordination) to severe (seizures and coma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1FE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"ZHANGW","dateModified":"2008-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0AE5-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Infection","valueDescription":"Infection and infestation","ValueMeaning":{"publicId":"2751403","version":"1","preferredName":"Infection and infestation","longName":"2751403","preferredDefinition":"A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0AF1-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0B0A-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Inflammation","valueDescription":"Inflammation","ValueMeaning":{"publicId":"2581231","version":"1","preferredName":"Inflammation","longName":"2581231","preferredDefinition":"A localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammation","conceptCode":"C3137","definition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A5C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-17","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0B16-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Injection Site Reaction","valueDescription":"Injection Site Reaction","ValueMeaning":{"publicId":"2751404","version":"1","preferredName":"Injection Site Reaction","longName":"2751404","preferredDefinition":"An intense reaction (usually immunologic) developing at the site of injection","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Injection Site Reaction","conceptCode":"C3508","definition":"An intense reaction (usually immunologic) developing at the site of injection","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0B23-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0B3C-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Insomnia","valueDescription":"Insomnia","ValueMeaning":{"publicId":"2751405","version":"1","preferredName":"Insomnia","longName":"2751405","preferredDefinition":"Difficulty in going to sleep or getting enough sleep.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Insomnia","conceptCode":"C28286","definition":"A sleep disorder characterized by difficulty in falling asleep and/or remaining asleep.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0B48-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0B61-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Lactose Intolerance","valueDescription":"Lactose Intolerance","ValueMeaning":{"publicId":"2751407","version":"1","preferredName":"Lactose Intolerance","longName":"2751407","preferredDefinition":"The disease state resulting from the absence of lactase enzyme in the musocal cells of the gastrointestinal tract, and therefore an inability to break down the disaccharide lactose in milk for absorption from the gastrointestinal tract. It is manifested by indigestion of a mild nature to severe diarrhea. It may be due to inborn defect genetically conditioned or may be acquired.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lactose Intolerance","conceptCode":"C3154","definition":"Inability to fully digest and absorb lactose due to limited or no lactase activity in the small intestine.  Congenital intolerance is inherited following an autosomal recessive pattern but is rare. It is more often due to a gradual decline of lactase production in adulthood following the ingestion of fewer lactose-containing foods or secondary to an intestinal mucosal brush-border injury. Prevalence is highest among Asians, Native Americans and Africans. Clinical signs include abdominal cramping, bloating, flatulence and diarrhea following the dietary intake of lactose.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0B70-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0B89-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Mood","valueDescription":"Mood","ValueMeaning":{"publicId":"2568311","version":"1","preferredName":"Mood","longName":"2568311v1.00","preferredDefinition":"A relatively temporary state of feeling.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mood","conceptCode":"C72883","definition":"A relatively temporary state of feeling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7E4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-30","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0B95-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Mucositis","valueDescription":"Mucositis","ValueMeaning":{"publicId":"2751408","version":"1","preferredName":"Mucositis","longName":"2751408","preferredDefinition":"A complication of some cancer therapies in which the lining of the digestive system becomes inflamed. Often seen as sores in the mouth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Mucositis","conceptCode":"C3853","definition":"Inflammation of the mucous membranes lining the gastrointestinal tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0BA2-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0BBB-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Muscle Spasm","valueDescription":"Muscle Spasm","ValueMeaning":{"publicId":"2751410","version":"1","preferredName":"Muscle Spasm","longName":"2751410","preferredDefinition":"A sudden, violent, involuntary contraction of a muscle or group of muscles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Muscle Spasm","conceptCode":"C50656","definition":"A sudden, violent, involuntary contraction of a muscle or group of muscles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0BCA-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0BE3-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Myalgia","valueDescription":"Myalgia","ValueMeaning":{"publicId":"2562563","version":"1","preferredName":"Myalgia","longName":"2562563v1.00","preferredDefinition":"Painful sensation originating from a muscle or group of muscles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myalgia","conceptCode":"C27009","definition":"Painful sensation originating from a muscle or group of muscles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C170-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-04","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-04","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0BEF-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Nausea","valueDescription":"Nausea","ValueMeaning":{"publicId":"2562807","version":"1","preferredName":"Nausea","longName":"2562807","preferredDefinition":"Nausea is the sensation of unease and discomfort from the stomach, with the sufferer feeling that he is about to vomit. (from Wikipedia)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nausea","conceptCode":"C3258","definition":"Upper abdominal discomfort associated with an urge to vomit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C264-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"ZHANGW","dateModified":"2008-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC907AE-0BFC-716C-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Local Anesthesia","valueDescription":"Local Anesthesia","ValueMeaning":{"publicId":"2751417","version":"1","preferredName":"Local Anesthesia","longName":"2751417v1.00","preferredDefinition":"The temporary suppression of sensation at a specific region of the body by pharmacological intervention. This type of anesthesia does not induce unconsciousness in the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Local Anesthesia Procedure","conceptCode":"C81260","definition":"The temporary suppression of sensation at a specific region of the body by pharmacological intervention. This type of anesthesia does not induce unconsciousness in the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC896A9-917C-11D8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC896A9-9195-11D8-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Line Patency","valueDescription":"Line Patency","ValueMeaning":{"publicId":"2751418","version":"1","preferredName":"Line Patency","longName":"2751418v1.00","preferredDefinition":"The status of an intravenous line or catheter as open.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Line Patency","conceptCode":"C200359","definition":"The status of an intravenous line or catheter as open.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC896A9-91A1-11D8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-07-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC896A9-91BA-11D8-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Line Occlusion","valueDescription":"Line Occlusion","ValueMeaning":{"publicId":"2751419","version":"1","preferredName":"Line Occlusion","longName":"2751419v1.00","preferredDefinition":"Blockage of a catheter tube.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Line Occlusion","conceptCode":"C200358","definition":"Blockage of a catheter tube.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC896A9-91C6-11D8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-07-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC896A9-91DF-11D8-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Leg cramps","valueDescription":"Leg cramps","ValueMeaning":{"publicId":"2751420","version":"1","preferredName":"Leg cramps","longName":"2751420v1.00","preferredDefinition":"An involuntary contraction of a muscle supporting the femur.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leg Cramp","conceptCode":"C34762","definition":"An involuntary contraction of a muscle supporting the femur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC896A9-91EB-11D8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC896A9-9204-11D8-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Nail Changes","valueDescription":"NAIL CHANGES","ValueMeaning":{"publicId":"2571196","version":"1","preferredName":"NAIL CHANGES","longName":"2571196v1.00","preferredDefinition":"Alteration of the normal characteristics of the fingernails or toenails. Examples include thickening, thinning, deformity, and separation from the nail bed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nail Changes","conceptCode":"C95556","definition":"Alteration of the normal characteristics of the fingernails or toenails. Examples include thickening, thinning, deformity, and separation from the nail bed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E329-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-07-26","endDate":null,"createdBy":"PWEST","dateCreated":"2004-07-26","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC896A9-921A-11D8-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Mouth Sores","valueDescription":"MOUTH SORES","ValueMeaning":{"publicId":"2570436","version":"1","preferredName":"MOUTH SORES","longName":"2570436v1.00","preferredDefinition":"An inflammatory lesion on the mucosal surface of the oral cavity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mouth Sore","conceptCode":"C27157","definition":"An inflammatory lesion on the mucosal surface of the oral cavity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E031-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":"5/26/23 jl.added concept to VM per cleanup activities for CCTG c","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC896A9-9230-11D8-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Metabolic Imbalance","valueDescription":"METABOLIC IMBALANCE","ValueMeaning":{"publicId":"2570435","version":"1","preferredName":"METABOLIC IMBALANCE","longName":"2570435v1.00","preferredDefinition":"Having to do with metabolism._The state of being out of equilibrium or out of proportion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metabolic","conceptCode":"C28240","definition":"Having to do with metabolism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Imbalance","conceptCode":"C200084","definition":"The state of being out of equilibrium or out of proportion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E030-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-06-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC896A9-9246-11D8-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Menopausal symptoms","valueDescription":"Natural Menopause","ValueMeaning":{"publicId":"2577374","version":"1","preferredName":"Natural Menopause","longName":"2577374","preferredDefinition":"(MEN-o-pawz) The time of life when a woman's menstrual periods stop permanently. Also called \"change of life.\"","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Menopause","conceptCode":"C3231","definition":"The permanent cessation of menses, usually defined by 6 to 12 months of amenorrhea in a woman over 45 years of age.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FB4B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2006-01-06","modifiedBy":"REEVESD","dateModified":"2009-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC896A9-925C-11D8-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Malignant Hyperthermia","valueDescription":"Malignant Hyperthermia","ValueMeaning":{"publicId":"2751421","version":"1","preferredName":"Malignant Hyperthermia","longName":"2751421v1.00","preferredDefinition":"A rare disorder characterized by rapid rise of the body temperature, accompanied by rhabdomyolysis and, if untreated, by collapse and death. It occurs in susceptible individuals who receive certain drugs for general anesthesia, gas anesthetics, or succinylcholine. It may be inherited in an autosomal dominant pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Hyperthermia Syndrome","conceptCode":"C84869","definition":"A rare disorder characterized by rapid rise of the body temperature, accompanied by rhabdomyolysis and, if untreated, by collapse and death. It occurs in susceptible individuals who receive certain drugs for general anesthesia, gas anesthetics, or succinylcholine. It may be inherited in an autosomal dominant pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC896A9-9269-11D8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC896A9-9282-11D8-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Malignancy","valueDescription":"Malignant Neoplasm","ValueMeaning":{"publicId":"2749852","version":"1","preferredName":"Malignant Neoplasm","longName":"2749852","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D47F93B-9A03-2D84-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC896A9-928E-11D8-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Macular degeneration","valueDescription":"Macular degeneration","ValueMeaning":{"publicId":"2751422","version":"1","preferredName":"Macular degeneration","longName":"2751422v1.00","preferredDefinition":"Loss of vision in the central portion of the retina (macula), secondary to retinal degeneration.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Macular Degeneration","conceptCode":"C123330","definition":"Loss of vision in the central portion of the retina (macula), secondary to retinal degeneration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC896A9-929B-11D8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC896A9-92B4-11D8-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Nausea and vomiting","valueDescription":"Nausea And Vomiting","ValueMeaning":{"publicId":"2751425","version":"1","preferredName":"Nausea And Vomiting","longName":"2751425","preferredDefinition":"Nausea is the sensation of unease and discomfort from the stomach, with the sufferer feeling that he is about to vomit. (from Wikipedia): An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Vomiting; the reflex act of ejecting the contents of the stomach through the mouth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nausea","conceptCode":"C3258","definition":"Upper abdominal discomfort associated with an urge to vomit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Vomiting","conceptCode":"C3442","definition":"Forceful ejection of the contents of the stomach through the mouth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC8C1F0-8FAF-1819-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC8C1F0-8FC8-1819-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Nasal Symptom","valueDescription":"NASAL SYMPTOM","ValueMeaning":{"publicId":"2570462","version":"1","preferredName":"NASAL SYMPTOM","longName":"2570462v1.00","preferredDefinition":"In reference to the nose._Subjective evidence of disease perceived by the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasal","conceptCode":"C27958","definition":"In reference to the nose.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E04B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC8C1F0-8FDD-1819-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Narcolepsy","valueDescription":"Narcolepsy","ValueMeaning":{"publicId":"2751426","version":"1","preferredName":"Narcolepsy","longName":"2751426v1.00","preferredDefinition":"A sleep disorder characterized by a tendency for excessive sleepiness during the day which occurs even after adequate sleep in the nighttime. The persons who suffer from this condition experience fatigue and may fall asleep at inappropriate times during the day.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Narcolepsy","conceptCode":"C84489","definition":"A sleep disorder characterized by a tendency for excessive sleepiness during the day which occurs even after adequate sleep in the nighttime. The persons who suffer from this condition experience fatigue and may fall asleep at inappropriate times during the day.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC8C1F0-8FEA-1819-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":"5/26/23 Added concept per cleanup activities for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC8C1F0-9003-1819-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Neuropathy","valueDescription":"Neuropathy","ValueMeaning":{"publicId":"2751427","version":"1","preferredName":"Neuropathy","longName":"2751427","preferredDefinition":"A disorder affecting the cranial nerves or the peripheral nervous system.  It is manifested with pain, tingling, numbness, and muscle weakness.  It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuropathy","conceptCode":"C4731","definition":"A disorder affecting the cranial nerves or the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC8C1F0-9010-1819-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC8C1F0-9029-1819-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Neutropenia","valueDescription":"Neutropenia","ValueMeaning":{"publicId":"2562753","version":"1","preferredName":"Neutropenia","longName":"2562753v1.00","preferredDefinition":"A decrease in the number of neutrophils in the peripheral blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neutropenia","conceptCode":"C80520","definition":"A decrease in the number of neutrophils in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C22E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC8C1F0-903E-1819-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Nutrition","valueDescription":"Nutrition","ValueMeaning":{"publicId":"2568352","version":"1","preferredName":"Nutrition","longName":"2568352","preferredDefinition":"The taking in and use of food and other nourishing material by the body.  Nutrition is a 3-part process.  First, food or drink is consumed.  Second, the body breaks down the food or drink into nutrients.  Third, the nutrients travel through the bloodstream to different parts of the body where they are used as ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nutrition","conceptCode":"C28294","definition":"That which is consumed to fuel necessary life processes of an organism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D80D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC8C1F0-904B-1819-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Osteoporosis","valueDescription":"Osteoporosis","ValueMeaning":{"publicId":"2566211","version":"1","preferredName":"Osteoporosis","longName":"2566211v1.00","preferredDefinition":"A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoporosis","conceptCode":"C3298","definition":"A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CFB0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-07-23","endDate":null,"createdBy":"CHANGM","dateCreated":"2003-07-23","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DC8C1F0-9058-1819-E044-0003BA3F9857","beginDate":"2008-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"REEVESD","dateModified":"2008-05-21","deletedIndicator":"No"},{"value":"Partial Thromboplastin Time (PTT) Prolongation","valueDescription":"Partial Thromboplastin Time (PTT) Prolongation","ValueMeaning":{"publicId":"2751448","version":"1","preferredName":"Partial Thromboplastin Time (PTT) Prolongation","longName":"2751448v1.00","preferredDefinition":"An abnormal laboratory test result in which the partial thromboplastin time is found to be greater than the control value. As a possible indicator of coagulopathy, a prolonged partial thromboplastin time (PTT) may occur in a variety of diseases and disorders, both primary and related to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prolonged Partial Thromboplastin Time","conceptCode":"C27028","definition":"An abnormal laboratory test result in which the partial thromboplastin time is found to be greater than the control value. As a possible indicator of coagulopathy, a prolonged partial thromboplastin time (PTT) may occur in a variety of diseases and disorders, both primary and related to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DCDBBEC-8159-741C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-22","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DCDBBEC-8172-741C-E044-0003BA3F9857","beginDate":"2008-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-22","modifiedBy":"REEVESD","dateModified":"2008-05-22","deletedIndicator":"No"},{"value":"Palliation","valueDescription":"Palliative therapy","ValueMeaning":{"publicId":"2570553","version":"1","preferredName":"Palliative therapy","longName":"2570553v1.00","preferredDefinition":"The patient- and family-centered active holistic care of patients with advanced, progressive disease. Essential components of palliative care are: pain and symptom control, communication regarding treatment and alternatives, prognosis, and available services, rehabilitation services, care that addresses treatment and palliative concerns, intellectual, emotional, social, and spiritual needs, terminal care, support in bereavement. The goal of palliative care is an achievement of the best quality of life for patients and their families.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Palliative Therapy","conceptCode":"C15292","definition":"The patient- and family-centered active holistic care of patients with advanced, progressive disease. Essential components of palliative care are: pain and symptom control, communication regarding treatment and alternatives, prognosis, and available services, rehabilitation services, care that addresses treatment and palliative concerns, intellectual, emotional, social, and spiritual needs, terminal care, support in bereavement. The goal of palliative care is an achievement of the best quality of life for patients and their families.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E0A6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DCDBBEC-8187-741C-E044-0003BA3F9857","beginDate":"2008-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-22","modifiedBy":"REEVESD","dateModified":"2008-05-22","deletedIndicator":"No"},{"value":"Pain","valueDescription":"Pain","ValueMeaning":{"publicId":"2566212","version":"1","preferredName":"Pain","longName":"2566212","preferredDefinition":"An unpleasant sensation induced by noxious stimuli and generally received by specialized nerve endings.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pain","conceptCode":"C3303","definition":"The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CFB1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-07-23","endDate":null,"createdBy":"CHANGM","dateCreated":"2003-07-23","modifiedBy":"REEVESD","dateModified":"2008-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DCDBBEC-8198-741C-E044-0003BA3F9857","beginDate":"2008-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-22","modifiedBy":"REEVESD","dateModified":"2008-05-22","deletedIndicator":"No"},{"value":"Parkinson's Disease","valueDescription":"Parkinson's Disease","ValueMeaning":{"publicId":"2751450","version":"1","preferredName":"Parkinson's Disease","longName":"2751450","preferredDefinition":"progressive, degenerative disorder of the nervous system characterized by tremors, rigidity, bradykinesia, postural instability, and gait abnormalities; caused by a loss of neurons and a decrease of dopamine in the basal ganglia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Parkinson Disease","conceptCode":"C26845","definition":"A progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra and the presence of Lewy bodies in the substantia nigra and locus coeruleus. Signs and symptoms include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements, a tendency to fall back, and a mask-like facial expression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DCDBBEC-81A7-741C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DCDBBEC-81C0-741C-E044-0003BA3F9857","beginDate":"2008-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-22","modifiedBy":"REEVESD","dateModified":"2008-05-22","deletedIndicator":"No"},{"value":"Phlebitis","valueDescription":"PHLEBITIS","ValueMeaning":{"publicId":"2570544","version":"1","preferredName":"PHLEBITIS","longName":"2570544","preferredDefinition":"Phlebitis; inflammation of a vein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phlebitis","conceptCode":"C38003","definition":"Inflammation of a vein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E09D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DCDBBEC-81CD-741C-E044-0003BA3F9857","beginDate":"2008-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-22","modifiedBy":"REEVESD","dateModified":"2008-05-22","deletedIndicator":"No"},{"value":"Pharyngitis","valueDescription":"PHARYNGITIS","ValueMeaning":{"publicId":"2570543","version":"1","preferredName":"PHARYNGITIS","longName":"2570543v1.00","preferredDefinition":"Inflammation of the throat most often caused by viral and bacterial infections. Other causes include allergens, chemical substances, and trauma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharyngitis","conceptCode":"C26851","definition":"Inflammation of the throat most often caused by viral and bacterial infections. Other causes include allergens, chemical substances, and trauma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E09C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DCDBBEC-81E3-741C-E044-0003BA3F9857","beginDate":"2008-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-22","modifiedBy":"REEVESD","dateModified":"2008-05-22","deletedIndicator":"No"},{"value":"Petechiae","valueDescription":"Petechia","ValueMeaning":{"publicId":"2751451","version":"1","preferredName":"Petechia","longName":"2751451","preferredDefinition":"(peh-TEH-kee-a) Pinpoint, unraised, round red spots under the skin caused by bleeding.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Petechia","conceptCode":"C3323","definition":"Purple or red hemorrhagic pinpoint spots in the skin or mucous membranes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DCDBBEC-81F0-741C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DCDBBEC-8209-741C-E044-0003BA3F9857","beginDate":"2008-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-22","modifiedBy":"REEVESD","dateModified":"2008-05-22","deletedIndicator":"No"},{"value":"Periodontal Disease","valueDescription":"Periodontal Disease","ValueMeaning":{"publicId":"2751452","version":"1","preferredName":"Periodontal Disease","longName":"2751452v1.00","preferredDefinition":"An inflammatory process of the gingival tissues and/or periodontal membrane of the teeth, resulting in an abnormally deep gingival sulcus, possibly producing periodontal pockets and loss of alveolar bone support.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Periodontal Disorder","conceptCode":"C63743","definition":"An inflammatory process of the gingival tissues and/or periodontal membrane of the teeth, resulting in an abnormally deep gingival sulcus, possibly producing periodontal pockets and loss of alveolar bone support.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DCDBBEC-8215-741C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-22","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":"5/26/23 Added concept per cleaning activities for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4DCDBBEC-822E-741C-E044-0003BA3F9857","beginDate":"2008-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-22","modifiedBy":"REEVESD","dateModified":"2008-05-22","deletedIndicator":"No"},{"value":"Chronic Obstructive Pulmonary Disease (COPD)","valueDescription":"Chronic Obstructive Pulmonary Disease","ValueMeaning":{"publicId":"2746206","version":"1","preferredName":"Chronic Obstructive Pulmonary Disease","longName":"2746206v1.00","preferredDefinition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Obstructive Pulmonary Disease","conceptCode":"C3199","definition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FB4F-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C3199 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FB68-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Antipsychotic","valueDescription":"Antipsychotic","ValueMeaning":{"publicId":"2746207","version":"1","preferredName":"Antipsychotic","longName":"2746207v1.00","preferredDefinition":"Also known as neuroleptics, major tranquilizers, or antischizophrenics, natural or synthetic. Antipsychotic Agents relieve and control the symptoms of schizophrenic illness (hallucinations, delusions, dementia). Most antipsychotic agents interfere with various neurotransmitter functions, often blocking dopamine receptors, and induce diverse behavioral, endocrine, motor-kinetic effects. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antipsychotic Agent","conceptCode":"C29710","definition":"Also known as neuroleptics, major tranquilizers, or antischizophrenics, natural or synthetic. Antipsychotic Agents relieve and control the symptoms of schizophrenic illness (hallucinations, delusions, dementia). Most antipsychotic agents interfere with various neurotransmitter functions, often blocking dopamine receptors, and induce diverse behavioral, endocrine, motor-kinetic effects. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FB74-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"CLOHNES","dateModified":"2023-05-16","changeDescription":null,"administrativeNotes":"5/16/23 updated VM with C29710 per cleanup actitivies cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FB8D-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Anti-angina","valueDescription":"Angina","ValueMeaning":{"publicId":"2574503","version":"1","preferredName":"Angina","longName":"2574503","preferredDefinition":"A heart condition marked by paroxysms of chest pain due to reduced oxygen to the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Angina","conceptCode":"C51221","definition":"Paroxysms of chest pain due to reduced oxygen to the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F014-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-12","modifiedBy":"CURTIST","dateModified":"2007-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FBA2-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Anesthesia","valueDescription":"Anesthetic Agent","ValueMeaning":{"publicId":"2746208","version":"1","preferredName":"Anesthetic Agent","longName":"2746208","preferredDefinition":"(an-es-THET-iks) Substances that cause loss of feeling or awareness. Local anesthetics cause loss of feeling in a part of the body. General anesthetics put the person to sleep.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anesthetic Agent","conceptCode":"C245","definition":"A pharmacological agent that acts in a reversible fashion and can be applied either locally or systemically to cause a partial or total loss of sensation and pain or to induce unconsciousness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FBAF-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FBC8-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Apheresis","valueDescription":"Pheresis","ValueMeaning":{"publicId":"2576539","version":"1","preferredName":"Pheresis","longName":"2576539v1.00","preferredDefinition":"A procedure that collects a component of the peripheral blood while returning the rest to the donor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pheresis","conceptCode":"C15191","definition":"A procedure that collects a component of the peripheral blood while returning the rest to the donor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F808-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-12","modifiedBy":"GDEEN","dateModified":"2023-08-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FBD4-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Allergy","valueDescription":"Allergy","ValueMeaning":{"publicId":"2570084","version":"1","preferredName":"Allergy","longName":"2570084v1.00","preferredDefinition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Allergic Reaction","conceptCode":"C114476","definition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DED1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FBE1-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Allergic Reaction","valueDescription":"Hypersensitivity","ValueMeaning":{"publicId":"2571810","version":"1","preferredName":"Hypersensitivity","longName":"2571810","preferredDefinition":"Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypersensitivity","conceptCode":"C3114","definition":"An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E58F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-08","modifiedBy":"REEVESD","dateModified":"2005-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FBF7-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Adrenal Suppression","valueDescription":"Adrenal Suppression","ValueMeaning":{"publicId":"2746209","version":"1","preferredName":"Adrenal Suppression","longName":"2746209v1.00","preferredDefinition":"Inadequate production of cortisol due to negative feedback on the hypothalamic-pituitary-adrenal axis that is caused by exposure to exogenous glucocorticoids or endogenous hypercortisolism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Suppression","conceptCode":"C200054","definition":"Inadequate production of cortisol due to negative feedback on the hypothalamic-pituitary-adrenal axis that is caused by exposure to exogenous glucocorticoids or endogenous hypercortisolism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FC04-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"CLOHNES","dateModified":"2023-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FC1D-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Acidity","valueDescription":"Acid","ValueMeaning":{"publicId":"2570050","version":"1","preferredName":"Acid","longName":"2570050","preferredDefinition":"A substance that yields hydrogen ions or protons in aqueous solutions; a substance capable of accepting a pair of electrons for the formation of a coordinate covalent bond; a substance whose hydrogen can be replaced by metals or basic radicals, or which react with bases to form salts and water.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acid","conceptCode":"C48057","definition":"A substance that yields hydrogen ions or protons in aqueous solutions; a substance capable of accepting a pair of electrons for the formation of a coordinate covalent bond; a substance whose hydrogen can be replaced by metals or basic radicals, or which react with bases to form salts and water.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DEAF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"KUMMEROA","dateModified":"2023-01-20","changeDescription":null,"administrativeNotes":"2023.1.20 Alt VM Name added per ticket request CADSR0001943. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FC32-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Accelerate Hematopoietic Recovery","valueDescription":"Accelerate Hematopoietic Recovery","ValueMeaning":{"publicId":"2746210","version":"1","preferredName":"Accelerate Hematopoietic Recovery","longName":"2746210v1.00","preferredDefinition":"Progress or happen at a faster rate._Pertaining to or related to the formation of blood cells._A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Accelerate","conceptCode":"C199668","definition":"Progress or happen at a faster rate.Progress or happen at a faster rate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hematopoietic","conceptCode":"C13324","definition":"Pertaining to or related to the formation of blood cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recovery","conceptCode":"C25746","definition":"A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FC3F-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"CLOHNES","dateModified":"2023-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FC58-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Alopecia","valueDescription":"Alopecia","ValueMeaning":{"publicId":"2562617","version":"1","preferredName":"Alopecia","longName":"2562617v1.00","preferredDefinition":"Hair loss usually from the scalp. It may result in bald spots or spread to the entire scalp or the entire epidermis. It may be androgenetic or caused by chemotherapeutic agents, compulsive hair pulling, autoimmune disorders or congenital conditions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alopecia","conceptCode":"C50575","definition":"Hair loss usually from the scalp. It may result in bald spots or spread to the entire scalp or the entire epidermis. It may be androgenetic or caused by chemotherapeutic agents, compulsive hair pulling, autoimmune disorders or congenital conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1A6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FC64-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Anemia","valueDescription":"Anemia","ValueMeaning":{"publicId":"2746211","version":"1","preferredName":"Anemia","longName":"2746211","preferredDefinition":"A reduction in the number of red blood cells per cu mm, the amount of hemoglobin in 100 ml of blood, and the volume of packed red blood cells per 100 ml of blood. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anemia","conceptCode":"C2869","definition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FC71-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FC8A-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Fever","valueDescription":"Fever","ValueMeaning":{"publicId":"2569501","version":"1","preferredName":"Fever","longName":"2569501","preferredDefinition":"Fever, also known as pyrexia, is the elevation of the body's temperature above the upper limit of normal, usually taken as 37.7 degrees C.  Most fevers are caused by infections and almost all infectious diseases cause fever. (Wikipedia)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fever","conceptCode":"C3038","definition":"Elevation of body temperature above normal due to inflammatory or immune responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC8A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7280-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Flatulence","valueDescription":"Flatulence","ValueMeaning":{"publicId":"2562791","version":"1","preferredName":"Flatulence","longName":"2562791v1.00","preferredDefinition":"A state of excessive gas in the alimentary canal.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Flatulence","conceptCode":"C37954","definition":"A state of excessive gas in the alimentary canal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C254-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-728D-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Gastric Ulcer","valueDescription":"Gastric Ulcer","ValueMeaning":{"publicId":"2746384","version":"1","preferredName":"Gastric Ulcer","longName":"2746384","preferredDefinition":"Ulceration of the mucous membrane of the stomach. (From Dorland, 28th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Ulcer","conceptCode":"C3388","definition":"An ulcerated lesion in the mucosal surface of the stomach. It may progress to involve the deeper layers of the gastric wall.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C20DB99-729A-0BA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-72B3-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Gastritis","valueDescription":"Gastritis","ValueMeaning":{"publicId":"2746385","version":"1","preferredName":"Gastritis","longName":"2746385","preferredDefinition":"Inflammation of the lining of the stomach.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastritis","conceptCode":"C26780","definition":"Inflammation of the stomach.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C20DB99-72BF-0BA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-72D8-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Gastroesophageal Reflux Disease","valueDescription":"Gastroesophageal Reflux Disease","ValueMeaning":{"publicId":"2746387","version":"1","preferredName":"Gastroesophageal Reflux Disease","longName":"2746387","preferredDefinition":"Reflux of gastric juice and/or duodenal contents (bile acids, pancreatic juice) into the distal esophagus, commonly due to incompetence of the lower esophageal sphincter. Gastric regurgitation is an extension of this process with entry of fluid into the pharynx or mouth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastroesophageal Reflux Disease","conceptCode":"C26781","definition":"A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C20DB99-72E7-0BA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7300-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Glaucoma","valueDescription":"Glaucoma","ValueMeaning":{"publicId":"2746388","version":"1","preferredName":"Glaucoma","longName":"2746388","preferredDefinition":"An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glaucoma","conceptCode":"C26782","definition":"Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C20DB99-730C-0BA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7325-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Gout","valueDescription":"Gout","ValueMeaning":{"publicId":"2746390","version":"1","preferredName":"Gout","longName":"2746390","preferredDefinition":"Hereditary metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of uric acid calculi.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gout","conceptCode":"C34650","definition":"A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C20DB99-7334-0BA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-734D-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Granulocytopenia","valueDescription":"Granulocytopenia","ValueMeaning":{"publicId":"2746392","version":"1","preferredName":"Granulocytopenia","longName":"2746392","preferredDefinition":"A decrease in the number of mature granulocytes (neutrophils, eosinophils, and basophils) in the peripheral blood. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Granulocytopenia","conceptCode":"C2863","definition":"A decrease in the number of mature granulocytes (neutrophils, eosinophils, and basophils) in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C20DB99-735C-0BA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7375-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Headache","valueDescription":"Headache","ValueMeaning":{"publicId":"2719266","version":"1","preferredName":"Headache","longName":"2719266","preferredDefinition":"Pain in various parts of the head, not confined to the area of distribution of any nerve.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Headache","conceptCode":"C34661","definition":"Pain in various parts of the head, not confined to the area of distribution of any nerve.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4351B20D-E735-1D1B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7381-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Hemorrhage","valueDescription":"Hemorrhage","ValueMeaning":{"publicId":"2684341","version":"1","preferredName":"Hemorrhage","longName":"2684341","preferredDefinition":"Bleeding or escape of blood from a vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AE3EE33-A095-31C3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-738E-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Flu Symptoms","valueDescription":"Influenza Symptom","ValueMeaning":{"publicId":"2746400","version":"1","preferredName":"Influenza Symptom","longName":"2746400","preferredDefinition":"An acute viral infection of the respiratory tract, occurring in isolated cases, in epidemics, or in pandemics; it is caused by serologically different strains of viruses (influenzaviruses) designated A, B, and C, has a 3-day incubation period, and usually lasts for 3 to 10 days. It is marked by inflammation of the nasal mucosa, pharynx, and conjunctiva; headache; myalgia; often fever, chills, and prostration; and occasionally involvement of the myocardium or central nervous system.: An indication that a person has a condition or disease.  Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Influenza","conceptCode":"C53482","definition":"An acute viral infection of the respiratory tract, occurring in isolated cases, in epidemics, or in pandemics; it is caused by serologically different strains of viruses (influenzaviruses) designated A, B, and C, has a 3-day incubation period, and usually lasts for 3 to 10 days. It is marked by inflammation of the nasal mucosa, pharynx, and conjunctiva; headache; myalgia; often fever, chills, and prostration; and occasionally involvement of the myocardium or central nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C23D46C-1A4D-1D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1A66-1D98-E044-0003BA3F9857","beginDate":"2008-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Hiccoughs","valueDescription":"Hiccough","ValueMeaning":{"publicId":"2577883","version":"1","preferredName":"Hiccough","longName":"2577883","preferredDefinition":"A diaphragmatic spasm causing a sudden inhalation which is interrupted by a spasmodic closure of the glottis, producing a noise. (On-line Medical Dictionary)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hiccough","conceptCode":"C37966","definition":"An involuntary contraction of the diaphragm against closed vocal cords, producing the \"hic\" sound.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD48-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-22","endDate":null,"createdBy":"HARDINGR","dateCreated":"2006-02-22","modifiedBy":"ONEDATA","dateModified":"2006-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1A7B-1D98-E044-0003BA3F9857","beginDate":"2008-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Hemorrhoids","valueDescription":"Hemorrhoid","ValueMeaning":{"publicId":"2746401","version":"1","preferredName":"Hemorrhoid","longName":"2746401","preferredDefinition":"Varicosities of the hemorrhoidal venous plexuses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhoid","conceptCode":"C26792","definition":"Dilated veins in the anal canal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C23D46C-1A88-1D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1AA1-1D98-E044-0003BA3F9857","beginDate":"2008-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Hand Foot Syndrome (HFS)","valueDescription":"Palmar-Plantar Erythodysthesia","ValueMeaning":{"publicId":"2746403","version":"1","preferredName":"Palmar-Plantar Erythodysthesia","longName":"2746403","preferredDefinition":"A condition marked by pain, swelling, numbness, tingling, or redness of the hands or feet. It sometimes occurs as a side effect of certain anticancer drugs. Also known as hand-foot syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Palmar-Plantar Erythrodysthesia","conceptCode":"C27177","definition":"A condition characterized by redness, pain, swelling, and tingling in the palms of the hands or the soles of the feet. It may appear as a side effect to chemotherapy agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C23D46C-1AB0-1D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1AC9-1D98-E044-0003BA3F9857","beginDate":"2008-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"GVHD Therapy","valueDescription":"Graft Versus Host Disease Therapy","ValueMeaning":{"publicId":"2746404","version":"1","preferredName":"Graft Versus Host Disease Therapy","longName":"2746404v1.00","preferredDefinition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C23D46C-1AD8-1D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1AF1-1D98-E044-0003BA3F9857","beginDate":"2008-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"GVHD Prophylaxis","valueDescription":"Graft Versus Host Disease Preventive Intervention","ValueMeaning":{"publicId":"2746405","version":"1","preferredName":"Graft Versus Host Disease Preventive Intervention","longName":"2746405","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.: An attempt to prevent disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C23D46C-1AFD-1D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1B16-1D98-E044-0003BA3F9857","beginDate":"2008-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Erectile Dysfunction","valueDescription":"Impotence","ValueMeaning":{"publicId":"2562636","version":"1","preferredName":"Impotence","longName":"2562636v1.00","preferredDefinition":"A disorder characterized by the persistent or recurrent inability to achieve or to maintain an erection during sexual activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Erectile Dysfunction","conceptCode":"C3133","definition":"A disorder characterized by the persistent or recurrent inability to achieve or to maintain an erection during sexual activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1B9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1B2B-1D98-E044-0003BA3F9857","beginDate":"2008-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Epiphora (Watery Eyes)","valueDescription":"Epiphora (Watery Eyes)","ValueMeaning":{"publicId":"2746406","version":"1","preferredName":"Epiphora (Watery Eyes)","longName":"2746406v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epiphora, CTCAE","conceptCode":"C55925","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C23D46C-1B38-1D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"CLOHNES","dateModified":"2023-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1B51-1D98-E044-0003BA3F9857","beginDate":"2008-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Empirical Coverage","valueDescription":"Empirical Coverage","ValueMeaning":{"publicId":"2746407","version":"1","preferredName":"Empirical Coverage","longName":"2746407v1.00","preferredDefinition":"Derived from experiment and observation rather than theory._Span a region or interval of distance, space or time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Empiric","conceptCode":"C54726","definition":"Derived from experiment and observation rather than theory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cover","conceptCode":"C68811","definition":"Span a region or interval of distance, space or time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C23D46C-1B5D-1D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C54726 and C68811 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1B76-1D98-E044-0003BA3F9857","beginDate":"2008-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Contrast Study","valueDescription":"Contrast Agent Image Study","ValueMeaning":{"publicId":"2746408","version":"1","preferredName":"Contrast Agent Image Study","longName":"2746408","preferredDefinition":"Substances used in radiography that allow visualization of certain tissues.: A radiographic technique used to evaluate a specific anatomic location for a specific purpose.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Contrast Agent","conceptCode":"C390","definition":"Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Image Study","conceptCode":"C63859","definition":"A radiographic technique used to evaluate a specific anatomic location for a specific purpose.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C23D46C-1B85-1D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1B9E-1D98-E044-0003BA3F9857","beginDate":"2008-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Congestion","valueDescription":"Congestion","ValueMeaning":{"publicId":"2746409","version":"1","preferredName":"Congestion","longName":"2746409v1.00","preferredDefinition":"The blockage of the nasal passage due to mucosal edema. It is usually the result of a viral infection or an allergic reaction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasal Congestion","conceptCode":"C78500","definition":"The blockage of the nasal passage due to mucosal edema. It is usually the result of a viral infection or an allergic reaction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C23D46C-1BAA-1D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C78500 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1BC3-1D98-E044-0003BA3F9857","beginDate":"2008-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Complicating Disease or Condition","valueDescription":"Complicating Disease or Condition","ValueMeaning":{"publicId":"2746410","version":"1","preferredName":"Complicating Disease or Condition","longName":"2746410v1.00","preferredDefinition":"Making more complex or intricate._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A state of being, such as a state of health.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complicating","conceptCode":"C25455","definition":"Making more complex or intricate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Condition","conceptCode":"C25457","definition":"A state of being, such as a state of health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C23D46C-1BCF-1D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"CLOHNES","dateModified":"2023-05-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1BE8-1D98-E044-0003BA3F9857","beginDate":"2008-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"CMV Therapy","valueDescription":"Cytomegalovirus Therapy","ValueMeaning":{"publicId":"2746411","version":"1","preferredName":"Cytomegalovirus Therapy","longName":"2746411v1.00","preferredDefinition":"A genus of the family herpesviridae, subfamily betaherpesvirinae, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytomegalovirus","conceptCode":"C14196","definition":"A genus of the family herpesviridae, subfamily betaherpesvirinae, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C23D46C-1BF7-1D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1C10-1D98-E044-0003BA3F9857","beginDate":"2008-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Bursitis","valueDescription":"Bursitis","ValueMeaning":{"publicId":"2746412","version":"1","preferredName":"Bursitis","longName":"2746412v1.00","preferredDefinition":"Painful inflammation of the bursa. It most often affects the hips, shoulders, and elbows.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bursitis","conceptCode":"C94407","definition":"Painful inflammation of the bursa. It most often affects the hips, shoulders, and elbows.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C23D46C-1C1C-1D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C94407 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1C35-1D98-E044-0003BA3F9857","beginDate":"2008-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Bony Disease","valueDescription":"Bony Disease","ValueMeaning":{"publicId":"2746413","version":"1","preferredName":"Bony Disease","longName":"2746413v1.00","preferredDefinition":"The structural organ comprised of specialized connective tissue that forms the skeletal components of the body._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone","conceptCode":"C12366","definition":"The structural organ comprised of specialized connective tissue that forms the skeletal components of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C23D46C-1C41-1D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"CLOHNES","dateModified":"2023-06-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1C5A-1D98-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Bloating","valueDescription":"Bloating","ValueMeaning":{"publicId":"2570112","version":"1","preferredName":"Bloating","longName":"2570112v1.00","preferredDefinition":"Distention of the abdomen associated with a feeling of fullness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bloating","conceptCode":"C78213","definition":"Distention of the abdomen associated with a feeling of fullness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DEED-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C78213 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1C6F-1D98-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Blepharitis (Eyelid Inflammation)","valueDescription":"Blepharitis","ValueMeaning":{"publicId":"2746414","version":"1","preferredName":"Blepharitis","longName":"2746414v1.00","preferredDefinition":"Inflammation of the eyelids near the eyelashes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blepharitis","conceptCode":"C112183","definition":"Inflammation of the eyelids near the eyelashes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C23D46C-1C7C-1D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"CLOHNES","dateModified":"2023-05-16","changeDescription":null,"administrativeNotes":"5/16/23 added C112183 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1C95-1D98-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Birth Control","valueDescription":"Contraception","ValueMeaning":{"publicId":"2576540","version":"1","preferredName":"Contraception","longName":"2576540","preferredDefinition":"The prevention of conception or impregnation by the use of devices or drugs or surgery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Contraception","conceptCode":"C37932","definition":"The prevention of conception or impregnation by the use of devices or drugs or surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F809-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-10-12","modifiedBy":"REEVESD","dateModified":"2007-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C23D46C-1CA1-1D98-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-01","modifiedBy":"REEVESD","dateModified":"2008-05-01","deletedIndicator":"No"},{"value":"Anticoagulation","valueDescription":"Anticoagulation","ValueMeaning":{"publicId":"2746212","version":"1","preferredName":"Anticoagulation","longName":"2746212v1.00","preferredDefinition":"Events or activities that prevent or inhibit coagulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Regulation of Coagulation","conceptCode":"C16299","definition":"Events or activities that prevent or inhibit coagulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FC96-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FCAF-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Anxiety","valueDescription":"Anxiety","ValueMeaning":{"publicId":"2746213","version":"1","preferredName":"Anxiety","longName":"2746213","preferredDefinition":"Apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anxiety","conceptCode":"C26696","definition":"Apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FCBB-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FCD4-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Appetite","valueDescription":"Appetite","ValueMeaning":{"publicId":"2746214","version":"1","preferredName":"Appetite","longName":"2746214","preferredDefinition":"A natural recurring desire for food. (On-line Medical Dictionary)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Appetite","conceptCode":"C25152","definition":"The natural recurring desire for food.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FCE0-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FCF9-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Arrhythmia","valueDescription":"Arrhythmia","ValueMeaning":{"publicId":"2573555","version":"1","preferredName":"Arrhythmia","longName":"2573555","preferredDefinition":"Arrhythmia; an abnormal rate of muscle contractions in the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arrhythmia","conceptCode":"C2881","definition":"Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EC60-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-15","modifiedBy":"REEVESD","dateModified":"2006-03-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FD05-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Arthralgia","valueDescription":"Arthralgia","ValueMeaning":{"publicId":"2562546","version":"1","preferredName":"Arthralgia","longName":"2562546v1.00","preferredDefinition":"Pain in a joint.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arthralgia","conceptCode":"C50464","definition":"Pain in a joint.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C15F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-04","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-04","modifiedBy":"GDEEN","dateModified":"2023-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FD1B-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Arthritis","valueDescription":"Arthritis","ValueMeaning":{"publicId":"2569498","version":"1","preferredName":"Arthritis","longName":"2569498","preferredDefinition":"Inflammation of a joint or a state characterized by inflammation of joints.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arthritis","conceptCode":"C2883","definition":"An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC87-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FD28-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Ascites","valueDescription":"Ascites","ValueMeaning":{"publicId":"2562643","version":"1","preferredName":"Ascites","longName":"2562643v1.00","preferredDefinition":"The accumulation of fluid in the peritoneal cavity, which may be serous, hemorrhagic, or the result of tumor metastasis to the peritoneum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peritoneal Effusion","conceptCode":"C2885","definition":"The accumulation of fluid in the peritoneal cavity, which may be serous, hemorrhagic, or the result of tumor metastasis to the peritoneum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1C0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FD35-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Asthma","valueDescription":"Asthma","ValueMeaning":{"publicId":"2570102","version":"1","preferredName":"Asthma","longName":"2570102v1.00","preferredDefinition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asthma","conceptCode":"C28397","definition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DEE3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-12","changeDescription":null,"administrativeNotes":"5/12/23 added C28397 to VM cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FD42-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Attention Deficit Disorder","valueDescription":"Attention Deficit Disorder","ValueMeaning":{"publicId":"2746216","version":"1","preferredName":"Attention Deficit Disorder","longName":"2746216","preferredDefinition":"behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity; although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant; symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Attention Deficit Hyperactivity Disorder, Inattentive Type","conceptCode":"C35092","definition":"A mental disorder characterized by inattention, easy distraction, careless mistakes and avoidance of tasks that require sustained mental focus. These behaviors can lead to maladaptive consequences in the affected individual's life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FD52-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FD6B-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Benign Prostatic Hyperplasia","valueDescription":"Benign Prostatic Hyperplasia","ValueMeaning":{"publicId":"2577137","version":"1","preferredName":"Benign Prostatic Hyperplasia","longName":"2577137","preferredDefinition":"A non-cancerous nodular enlargement of the prostate gland.  It is characterized by the presence of epithelial cell nodules, and stromal nodules containing fibrous and smooth muscle elements.  It is the most common urologic disorder in men, causing blockage of urine flow.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign Prostatic Hyperplasia","conceptCode":"C2897","definition":"A non-cancerous nodular enlargement of the prostate gland.  It is characterized by the presence of epithelial cell nodules, and stromal nodules containing fibrous and smooth muscle elements.  It is the most common urologic disorder in men, causing blockage of urine flow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA5E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FD80-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Bipolar Disorder","valueDescription":"Bipolar Disorder","ValueMeaning":{"publicId":"2746218","version":"1","preferredName":"Bipolar Disorder","longName":"2746218","preferredDefinition":"A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bipolar Disorder","conceptCode":"C34423","definition":"A disorder of the brain that causes unusual shifts in mood, energy, activity levels and the ability to carry out day-to-day tasks. Often these moods range and shift from periods of elation and energized behavior to those of hopelessness and depression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FD90-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FDA9-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Bronchitis","valueDescription":"Bronchitis","ValueMeaning":{"publicId":"2573311","version":"1","preferredName":"Bronchitis","longName":"2573311v1.00","preferredDefinition":"An acute or chronic inflammatory process affecting the bronchi.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bronchitis","conceptCode":"C2911","definition":"An acute or chronic inflammatory process affecting the bronchi.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EB6C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-22","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C2911 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FDB5-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Bronchospasm","valueDescription":"Bronchospasm","ValueMeaning":{"publicId":"2746219","version":"1","preferredName":"Bronchospasm","longName":"2746219","preferredDefinition":"Spasmodic contraction of the smooth muscle of the bronchi.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bronchospasm","conceptCode":"C34439","definition":"Sudden contraction of the smooth muscles of the bronchial wall.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FDC2-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FDDB-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Cardiac","valueDescription":"Cardiac","ValueMeaning":{"publicId":"2746220","version":"1","preferredName":"Cardiac","longName":"2746220","preferredDefinition":"Having to do with the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiac","conceptCode":"C13306","definition":"Having to do with the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FDE7-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FE00-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Cellulitis","valueDescription":"Cellulitis","ValueMeaning":{"publicId":"2746221","version":"1","preferredName":"Cellulitis","longName":"2746221","preferredDefinition":"An acute, spreading infection of the deep tissues of the skin and muscle that causes the skin to become warm and tender and may also cause fever, chills, swollen lymph nodes, and blisters.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cellulitis","conceptCode":"C26715","definition":"Inflammation of the dermis and subcutaneous tissues caused by a bacterial infection. Symptoms include erythema, edema, and pain to the affected area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FE0C-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FE25-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Conjunctivitis","valueDescription":"Conjunctivitis","ValueMeaning":{"publicId":"2746222","version":"1","preferredName":"Conjunctivitis","longName":"2746222","preferredDefinition":"Conjunctivitis; inflammation of the conjunctiva of the eye.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Conjunctivitis","conceptCode":"C34504","definition":"Inflammation of the conjunctiva of the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FE33-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FE4C-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Constipation","valueDescription":"Constipation","ValueMeaning":{"publicId":"2562669","version":"1","preferredName":"Constipation","longName":"2562669v1.00","preferredDefinition":"Irregular and infrequent or difficult evacuation of the bowels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Constipation","conceptCode":"C37930","definition":"Irregular and infrequent or difficult evacuation of the bowels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1DA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C175B6C-FE58-2303-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Cough","valueDescription":"Cough","ValueMeaning":{"publicId":"2562655","version":"1","preferredName":"Cough","longName":"2562655","preferredDefinition":"A sudden, often repetitive, spasmodic contraction of the thoracic cavity, resulting in violent release of air from the lungs, and usually accompanied by a distinctive sound.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cough","conceptCode":"C37935","definition":"A sudden, often repetitive, spasmodic contraction of the thoracic cavity, resulting in violent release of air from the lungs, and usually accompanied by a distinctive sound.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1CC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C16B073-3A15-3FCC-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Dehydration","valueDescription":"Dehydration","ValueMeaning":{"publicId":"2562690","version":"1","preferredName":"Dehydration","longName":"2562690v1.00","preferredDefinition":"A condition resulting from the excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dehydration","conceptCode":"C26740","definition":"A condition resulting from the excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1EF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C16B073-3A22-3FCC-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Depression","valueDescription":"Depression","ValueMeaning":{"publicId":"2746223","version":"1","preferredName":"Depression","longName":"2746223","preferredDefinition":"Depression; a mental state of depressed mood characterised by feelings of sadness, despair and discouragement. (On-line Medical Dictionary)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Depression","conceptCode":"C2982","definition":"A melancholy feeling of sadness and despair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C16B073-3A2F-3FCC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C16B073-3A48-3FCC-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Dermatitis","valueDescription":"Dermatitis","ValueMeaning":{"publicId":"2568577","version":"1","preferredName":"Dermatitis","longName":"2568577v1.00","preferredDefinition":"An inflammatory process affecting the skin. Signs include red rash, itching, and blister formation. Representative examples are contact dermatitis, atopic dermatitis, and seborrheic dermatitis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dermatitis","conceptCode":"C2983","definition":"An inflammatory process affecting the skin. Signs include red rash, itching, and blister formation. Representative examples are contact dermatitis, atopic dermatitis, and seborrheic dermatitis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D8EE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-24","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-02-24","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 Added C2983 for cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C16B073-3A5D-3FCC-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Diarrhea","valueDescription":"Diarrhea","ValueMeaning":{"publicId":"2571847","version":"1","preferredName":"Diarrhea","longName":"2571847v1.00","preferredDefinition":"Watery bowel movements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diarrhea","conceptCode":"C2987","definition":"Watery bowel movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E5B4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-09-13","modifiedBy":"CLOHNES","dateModified":"2023-05-17","changeDescription":null,"administrativeNotes":"5/17/23 added C2987 per cleanup activities cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C16B073-3A6A-3FCC-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"HIV","valueDescription":"Human Immunodeficiency Virus","ValueMeaning":{"publicId":"2567494","version":"1","preferredName":"Human Immunodeficiency Virus","longName":"2567494","preferredDefinition":"Human immunodeficiency virus. Species of LENTIVIRUS, subgenus primate lentiviruses (LENTIVIRUSES, PRIMATE), formerly designated T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). It is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the ACQUIRED IMMUNODEFICIENCY SYNDROME.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Immunodeficiency Virus","conceptCode":"C14219","definition":"The virus isolated and recognized as the etiologic agent of AIDS. HIV-1 is classified as a lentivirus, a subtype of retroviruses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D4B3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-19","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7147-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"CNS Disease","valueDescription":"Central Nervous System Disease or Disorder","ValueMeaning":{"publicId":"2746379","version":"1","preferredName":"Central Nervous System Disease or Disorder","longName":"2746379","preferredDefinition":"The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C20DB99-7157-0BA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7170-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Diabetes","valueDescription":"Diabetes Mellitus","ValueMeaning":{"publicId":"2573558","version":"1","preferredName":"Diabetes Mellitus","longName":"2573558","preferredDefinition":"(dye-a-BEE-teez) A disease in which the body does not properly control the amount of sugar in the blood. As a result, the level of sugar in the blood is too high. This disease occurs when the body does not produce enough insulin or does not use it properly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EC63-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-15","modifiedBy":"CZECHS","dateModified":"2008-06-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-717C-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Dyspepsia","valueDescription":"Dyspepsia","ValueMeaning":{"publicId":"2562748","version":"1","preferredName":"Dyspepsia","longName":"2562748v1.00","preferredDefinition":"An uncomfortable, often painful feeling in the stomach, resulting from impaired digestion. Symptoms include burning stomach pain, bloating, heartburn, nausea, and vomiting. Causes include gastritis, gastric ulcer, gastroesophageal reflux disease, pancreatic disease, and gallbladder disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dyspepsia","conceptCode":"C26756","definition":"An uncomfortable, often painful feeling in the stomach, resulting from impaired digestion. Symptoms include burning stomach pain, bloating, heartburn, nausea, and vomiting. Causes include gastritis, gastric ulcer, gastroesophageal reflux disease, pancreatic disease, and gallbladder disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C229-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7189-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Dysphagia","valueDescription":"Dysphagia","ValueMeaning":{"publicId":"2562767","version":"1","preferredName":"Dysphagia","longName":"2562767v1.00","preferredDefinition":"A symptom referring to difficulty in swallowing. It may be observed in patients with stroke, motor neuron disorders, cancer of the throat or mouth, head and neck injuries, Parkinson disease, and multiple sclerosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dysphagia","conceptCode":"C2980","definition":"A symptom referring to difficulty in swallowing. It may be observed in patients with stroke, motor neuron disorders, cancer of the throat or mouth, head and neck injuries, Parkinson disease, and multiple sclerosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C23C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7196-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Dyspnea","valueDescription":"Dyspnea","ValueMeaning":{"publicId":"2739312","version":"1","preferredName":"Dyspnea","longName":"2739312","preferredDefinition":"An uncomfortable sensation of difficulty breathing. It may present as an acute or chronic sign of an underlying respiratory or heart disorder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dyspnea","conceptCode":"C2998","definition":"An uncomfortable sensation of difficulty breathing. It may present as an acute or chronic sign of an underlying respiratory or heart disorder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A4E258C-7177-3C04-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-07","modifiedBy":"TAYLORT","dateModified":"2020-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-71AC-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Dysuria","valueDescription":"Dysuria","ValueMeaning":{"publicId":"2562637","version":"1","preferredName":"Dysuria","longName":"2562637v1.00","preferredDefinition":"Pain or discomfort during urination.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dysuria","conceptCode":"C2999","definition":"Pain or discomfort during urination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1BA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-71B8-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Earache","valueDescription":"Earache","ValueMeaning":{"publicId":"2562719","version":"1","preferredName":"Earache","longName":"2562719v1.00","preferredDefinition":"Painful sensation in the ear region.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ear Pain","conceptCode":"C37944","definition":"Painful sensation in the ear region.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C20C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-71CE-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Edema","valueDescription":"Edema","ValueMeaning":{"publicId":"2567005","version":"1","preferredName":"Edema","longName":"2567005v1.00","preferredDefinition":"Accumulation of an excessive amount of fluid in cells or intercellular tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Edema","conceptCode":"C3002","definition":"Accumulation of an excessive amount of fluid in cells or intercellular tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D2CA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-09-10","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-09-10","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-71DB-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Electrolyte Imbalance","valueDescription":"Electrolyte Imbalance","ValueMeaning":{"publicId":"2746381","version":"1","preferredName":"Electrolyte Imbalance","longName":"2746381","preferredDefinition":"Higher or lower than normal values for the serum electrolytes; usually affecting NA, K, CHL, CO2, glucose, bun.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Electrolyte Imbalance","conceptCode":"C50545","definition":"Higher or lower than normal values for the serum electrolytes; usually affecting NA, K, CHL, CO2, glucose, bun.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C20DB99-71EB-0BA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7204-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Engraftment","valueDescription":"Engraftment","ValueMeaning":{"publicId":"2746382","version":"1","preferredName":"Engraftment","longName":"2746382","preferredDefinition":"The establishment of viable, functional grafted tissue within the body of a host.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Engraftment","conceptCode":"C37947","definition":"The establishment of viable, functional grafted tissue within the body of a host.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C20DB99-7210-0BA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7229-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Epistaxis","valueDescription":"Epistaxis","ValueMeaning":{"publicId":"2562545","version":"1","preferredName":"Epistaxis","longName":"2562545v1.00","preferredDefinition":"Bleeding from the nose.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epistaxis","conceptCode":"C26766","definition":"Bleeding from the nose.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C15E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-04","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-04","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7235-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Erythema","valueDescription":"Erythema","ValueMeaning":{"publicId":"2585191","version":"1","preferredName":"Erythema","longName":"2585191","preferredDefinition":"Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of causes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Erythema","conceptCode":"C26901","definition":"Red discoloration of the skin caused by infectious agents, inflammation, drug hypersensitivity, or underlying disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26809F27-C2D0-70B5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7242-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Esophagitis","valueDescription":"Esophagitis","ValueMeaning":{"publicId":"2746383","version":"1","preferredName":"Esophagitis","longName":"2746383","preferredDefinition":"Inflammation, acute or chronic, of the esophagus caused by bacteria, chemicals, or trauma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophagitis","conceptCode":"C9224","definition":"An acute or chronic inflammatory process affecting the esophageal wall.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C20DB99-724E-0BA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7267-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Fatigue","valueDescription":"Fatigue","ValueMeaning":{"publicId":"2562609","version":"1","preferredName":"Fatigue","longName":"2562609v1.00","preferredDefinition":"Overall tiredness and lack of energy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fatigue","conceptCode":"C3036","definition":"Overall tiredness and lack of energy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C19E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CLOHNES","dateModified":"2023-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C20DB99-7273-0BA9-E044-0003BA3F9857","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"REEVESD","dateModified":"2008-04-30","deletedIndicator":"No"},{"value":"Pancreatic insufficiency","valueDescription":"Pancreatic Insufficiency","ValueMeaning":{"publicId":"2955753","version":"1","preferredName":"Pancreatic Insufficiency","longName":"2955753","preferredDefinition":"Inability of the exocrine pancreas to produce and secrete an adequate amount of digestive enzymes into the small intestine.  Patients present with symptoms of malabsorption syndrome, abdominal discomfort, and bloating.  Causes include chronic pancreatitis, cystic fibrosis, and autoimmune disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Insufficiency","conceptCode":"C84316","definition":"Inability of the exocrine pancreas to produce and secrete an adequate amount of digestive enzymes into the small intestine.  Patients present with symptoms of malabsorption syndrome, abdominal discomfort, and bloating.  Causes include chronic pancreatitis, cystic fibrosis, and autoimmune disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"769BA032-1319-045A-E040-BB89AD431EE2","latestVersionIndicator":"Yes","beginDate":"2009-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"769BA032-1332-045A-E040-BB89AD431EE2","beginDate":"2009-10-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-23","modifiedBy":"ONEDATA","dateModified":"2009-10-23","deletedIndicator":"No"},{"value":"Wheezing","valueDescription":"Wheezing","ValueMeaning":{"publicId":"2943827","version":"1","preferredName":"Wheezing","longName":"2943827","preferredDefinition":"A symptom and a finding during physical examination, characterized by a high-pitched, whistling sound during breathing. It results from the narrowing or obstruction of the respiratory airways. The most common causes of wheezing are asthma, chronic obstructive pulmonary disease, tracheobronchitis, and pulmonary edema.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Wheezing","conceptCode":"C78718","definition":"A symptom and a finding during physical examination, characterized by a high-pitched, whistling sound during breathing. It results from the narrowing or obstruction of the respiratory airways. The most common causes of wheezing are asthma, chronic obstructive pulmonary disease, tracheobronchitis, and pulmonary edema.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7428BBDA-1E2F-B2E3-E040-BB89AD4317E1","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"81FF40F5-1512-7087-E040-BB89AD430CCD","beginDate":"2010-03-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-17","modifiedBy":"ONEDATA","dateModified":"2010-03-17","deletedIndicator":"No"},{"value":"Immunosuppression","valueDescription":"Immunosuppression","ValueMeaning":{"publicId":"3117302","version":"1","preferredName":"Immunosuppression","longName":"3117302","preferredDefinition":"An Immunosuppressive Effect involves interference with, or restraint of, the function of biologic molecules and complexes, or cellular, cell, or tissue components of a normal immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunosuppressive Effect","conceptCode":"C40913","definition":"An Immunosuppressive Effect involves interference with, or restraint of, the function of biologic molecules and complexes, or cellular, cell, or tissue components of a normal immune response.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A9A61A9-8113-8B51-E040-BB89AD43333D","latestVersionIndicator":"Yes","beginDate":"2010-07-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A9A61A9-812C-8B51-E040-BB89AD43333D","beginDate":"2010-07-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-04","modifiedBy":"ONEDATA","dateModified":"2010-07-04","deletedIndicator":"No"},{"value":"Myasthenia Gravis","valueDescription":"Myasthenia Gravis","ValueMeaning":{"publicId":"3143924","version":"1","preferredName":"Myasthenia Gravis","longName":"3143924","preferredDefinition":"A chronic autoimmune neuromuscular disorder characterized by skeletal muscle weakness.  It is caused by the blockage of the acetylcholine receptors at the neuromuscular junction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myasthenia Gravis","conceptCode":"C60989","definition":"A chronic autoimmune neuromuscular disorder characterized by skeletal muscle weakness. It is caused by the blockage of the acetylcholine receptors at the neuromuscular junction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9167B9F7-3DD6-C748-E040-BB89AD432898","latestVersionIndicator":"Yes","beginDate":"2010-09-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-29","modifiedBy":"KUMMEROA","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9167B9F7-3DEF-C748-E040-BB89AD432898","beginDate":"2010-09-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-29","modifiedBy":"ONEDATA","dateModified":"2010-09-29","deletedIndicator":"No"},{"value":"Anorexia","valueDescription":"Anorexia","ValueMeaning":{"publicId":"3123184","version":"1","preferredName":"Anorexia","longName":"3123184","preferredDefinition":"A disorder characterized by a loss of appetite.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anorexia","conceptCode":"E12252","definition":"A disorder characterized by a loss of appetite.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BBCC8B4-9567-4A67-E040-BB89AD432BF5","latestVersionIndicator":"Yes","beginDate":"2010-07-19","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-07-19","modifiedBy":"ONEDATA","dateModified":"2010-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE14ED62-E4C0-696C-E040-BB89AD434A12","beginDate":"2011-09-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Rhinitis","valueDescription":"Rhinitis","ValueMeaning":{"publicId":"3287377","version":"1","preferredName":"Rhinitis","longName":"3287377","preferredDefinition":"An inflammation of the mucous membrane lining the nose, usually associated with nasal discharge.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rhinitis","conceptCode":"C34986","definition":"An inflammation of the mucous membrane lining the nose, usually associated with nasal discharge.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE14ED62-E4CB-696C-E040-BB89AD434A12","latestVersionIndicator":"Yes","beginDate":"2011-09-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE14ED62-E4E4-696C-E040-BB89AD434A12","beginDate":"2011-09-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-29","modifiedBy":"ONEDATA","dateModified":"2011-09-29","deletedIndicator":"No"},{"value":"Attention Deficit Hyperactivity Disorder (ADHD)","valueDescription":"Attention Deficit Hyperactivity Disorder","ValueMeaning":{"publicId":"3345178","version":"1","preferredName":"Attention Deficit Hyperactivity Disorder","longName":"3345178","preferredDefinition":"A disorder characterized by a marked pattern of inattention and/or hyperactivity-impulsivity that is inconsistent with developmental level and clearly interferes with functioning in at least two settings (e.g. at home and at school). At least some of the symptoms must be present before the age of 7 years.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Attention Deficit Hyperactivity Disorder","conceptCode":"C97160","definition":"A disorder characterized by a marked pattern of inattention and/or hyperactivity-impulsivity that is inconsistent with developmental level and clearly interferes with functioning in at least two settings (e.g. at home and at school). When present, the symptoms of hyperactivity are most often present before the age of 7 years. There are three recognized presentations or subtypes from most to least common: combined type, inattentive/distractible type, hyperactive/impulsive type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6163BC4-687A-9809-E040-BB89AD43690E","latestVersionIndicator":"Yes","beginDate":"2012-01-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-01-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6163BC4-6893-9809-E040-BB89AD43690E","beginDate":"2012-01-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-01-09","modifiedBy":"ONEDATA","dateModified":"2012-01-09","deletedIndicator":"No"},{"value":"Airway Protection","valueDescription":"Airway Protection","ValueMeaning":{"publicId":"3729331","version":"1","preferredName":"Airway Protection","longName":"3729331v1.00","preferredDefinition":"Mechanical methods to maintain an open trachea, such as intubation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Airway Protection","conceptCode":"C200357","definition":"Mechanical methods to maintain an open trachea, such as intubation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB0AE5B4-28A8-05FD-E040-BB89AD437DD3","latestVersionIndicator":"Yes","beginDate":"2013-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-23","modifiedBy":"CLOHNES","dateModified":"2023-07-06","changeDescription":null,"administrativeNotes":"7/6/23 Added concept to VM cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB0AE5B4-28C1-05FD-E040-BB89AD437DD3","beginDate":"2013-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-23","modifiedBy":"ONEDATA","dateModified":"2013-04-23","deletedIndicator":"No"},{"value":"Mental Status Changes","valueDescription":"Mental Status change","ValueMeaning":{"publicId":"3729332","version":"1","preferredName":"Mental Status change","longName":"3729332","preferredDefinition":"The act of alteration or modification; changed or altered in form or character.: A condition or state at a particular time.: Conceptual functions or thinking in all its forms. (NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mental Process","conceptCode":"C16840","definition":"Any cognitive activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB0AE5B4-28CF-05FD-E040-BB89AD437DD3","latestVersionIndicator":"Yes","beginDate":"2013-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB0AE5B4-28E8-05FD-E040-BB89AD437DD3","beginDate":"2013-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-23","modifiedBy":"ONEDATA","dateModified":"2013-04-23","deletedIndicator":"No"},{"value":"Pulmonary Edema","valueDescription":"Pulmonary Edema","ValueMeaning":{"publicId":"2946063","version":"1","preferredName":"Pulmonary Edema","longName":"2946063","preferredDefinition":"Accumulation of fluid in the lung tissues causing disturbance of the gas exchange that may lead to respiratory failure. It is caused by direct injury to the lung parenchyma or congestive heart failure. The symptoms may appear suddenly or gradually. Suddenly appearing symptoms include difficulty breathing, feeling of suffocation, and coughing associated with frothy sputum. Gradually appearing symptoms include difficulty breathing while lying in bed, shortness of breath during activity, and weight gain (in patients with congestive heart failure).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Edema","conceptCode":"C26868","definition":"Accumulation of fluid in the lung tissues causing disturbance of the gas exchange that may lead to respiratory failure. It is caused by direct injury to the lung parenchyma or congestive heart failure. The symptoms may appear suddenly or gradually. Suddenly appearing symptoms include difficulty breathing, feeling of suffocation, and coughing associated with frothy sputum. Gradually appearing symptoms include difficulty breathing while lying in bed, shortness of breath during activity, and weight gain (in patients with congestive heart failure).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746AE5AE-6516-370C-E040-BB89AD4351E3","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB0AE5B4-28FC-05FD-E040-BB89AD437DD3","beginDate":"2013-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-23","modifiedBy":"ONEDATA","dateModified":"2013-04-23","deletedIndicator":"No"},{"value":"Renal Failure","valueDescription":"Renal Failure","ValueMeaning":{"publicId":"2768982","version":"1","preferredName":"Renal Failure","longName":"2768982","preferredDefinition":"Acute or chronic condition, characterized by the inability of the kidneys to adequately filter the blood substances, resulting in uremia and electrolyte imbalances.  Acute renal failure is usually associated with oliguria or anuria, hyperkalemia, and pulmonary edema.  Chronic renal failure is irreversible and requires hemodialysis.--2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Failure","conceptCode":"C4376","definition":"An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-968B-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"COLBERTM","dateModified":"2023-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB0AE5B4-2907-05FD-E040-BB89AD437DD3","beginDate":"2013-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-23","modifiedBy":"ONEDATA","dateModified":"2013-04-23","deletedIndicator":"No"},{"value":"Respiratory Failure","valueDescription":"Respiratory Failure","ValueMeaning":{"publicId":"2946095","version":"1","preferredName":"Respiratory Failure","longName":"2946095","preferredDefinition":"Impaired gas exchange by the respiratory system resulting in hypoxemia and decreased oxygenation of the tissues that may be associated with increased arterial levels of carbon dioxide. Causes include chronic obstructive pulmonary disease, asthma, emphysema, acute respiratory distress syndrome, pneumonia, pulmonary edema, pneumothorax, and congestive heart failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Respiratory Failure","conceptCode":"C26872","definition":"The significant impairment of gas exchange within the lungs resulting in hypoxia, hypercarbia, or both, to the extent that organ tissue perfusion is severely compromised. Causes include chronic obstructive pulmonary disease, asthma, emphysema, acute respiratory distress syndrome, pneumonia, pulmonary edema, pneumothorax, and congestive heart failure. Treatment requires intubation and mechanical ventilation until the time the lungs recover sufficient function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746AE5AE-679E-370C-E040-BB89AD4351E3","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB0AE5B4-291C-05FD-E040-BB89AD437DD3","beginDate":"2013-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-23","modifiedBy":"ONEDATA","dateModified":"2013-04-23","deletedIndicator":"No"},{"value":"Somnolence","valueDescription":"Somnolence","ValueMeaning":{"publicId":"3121762","version":"1","preferredName":"Somnolence","longName":"3121762","preferredDefinition":"A disorder characterized by characterized by excessive sleepiness and drowsiness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Somnolence","conceptCode":"E12814","definition":"A disorder characterized by characterized by excessive sleepiness and drowsiness.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B6C5DD5-CF73-4885-E040-BB89AD4353DF","latestVersionIndicator":"Yes","beginDate":"2010-07-15","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-07-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB0AE5B4-2927-05FD-E040-BB89AD437DD3","beginDate":"2013-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-23","modifiedBy":"ONEDATA","dateModified":"2013-04-23","deletedIndicator":"No"},{"value":"Confusion","valueDescription":"Confusion","ValueMeaning":{"publicId":"4614753","version":"1","preferredName":"Confusion","longName":"4614753","preferredDefinition":"Impaired orientation to person, place or time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confusion","conceptCode":"C37928","definition":"A mental state characterized by a lack of clear and orderly thought and behavior.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"08EE1F25-CD68-F7EA-E050-BB89AD432750","latestVersionIndicator":"Yes","beginDate":"2014-11-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09CDA8D6-8B79-E114-E050-BB89AD431FA5","beginDate":"2014-12-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-09","modifiedBy":"ONEDATA","dateModified":"2014-12-09","deletedIndicator":"No"},{"value":"Uveitis","valueDescription":"Uveitis","ValueMeaning":{"publicId":"2943903","version":"1","preferredName":"Uveitis","longName":"2943903","preferredDefinition":"An inflammatory process affecting a part of or the entire uvea. Causes include inflammatory agents (e.g., herpes simplex, herpes zoster, leptospirosis) and systemic diseases (e.g., inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus, ankylosing spondylitis). Patients present with pain and redness in the eye, light sensitivity, and blurred and decreased vision.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uveitis","conceptCode":"C26909","definition":"An inflammatory process affecting a part of or the entire uvea. Causes include inflammatory agents (e.g., herpes simplex, herpes zoster, leptospirosis) and systemic diseases (e.g., inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus, ankylosing spondylitis). Patients present with pain and redness in the eye, light sensitivity, and blurred and decreased vision.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742B257F-AA72-95B9-E040-BB89AD4354AE","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C95F791-732F-0539-E050-BB89AD433951","beginDate":"2015-08-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-08-05","modifiedBy":"ONEDATA","dateModified":"2015-08-05","deletedIndicator":"No"},{"value":"Surgery","valueDescription":"Surgical Procedure","ValueMeaning":{"publicId":"3440172","version":"1","preferredName":"Surgical Procedure","longName":"3440172","preferredDefinition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgical Procedure","conceptCode":"C15329","definition":"A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE12571D-0867-9ACA-E040-BB89AD4324C1","latestVersionIndicator":"Yes","beginDate":"2012-04-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-19","modifiedBy":"KUMMEROA","dateModified":"2024-02-22","changeDescription":"Added OBIB alternate name and identifier DW 03-21-2019","administrativeNotes":"2023.1.20 Alt VM added per ticket request CADSR0001943. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2203C0A2-0CEC-1EFA-E050-BB89AD437782","beginDate":"2015-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-13","modifiedBy":"ONEDATA","dateModified":"2015-10-13","deletedIndicator":"No"},{"value":"Colitis","valueDescription":"Colitis","ValueMeaning":{"publicId":"2684803","version":"1","preferredName":"Colitis","longName":"2684803","preferredDefinition":"Inflammation of the colon.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colitis","conceptCode":"C26723","definition":"Inflammation of the colon.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B0AABC6-5698-5AC2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-09-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"49C18FD0-238B-6CA0-E053-F662850A09FE","beginDate":"2017-03-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-02","modifiedBy":"ONEDATA","dateModified":"2017-03-02","deletedIndicator":"No"},{"value":"Dizziness","valueDescription":"Dizziness","ValueMeaning":{"publicId":"5734015","version":"1","preferredName":"Dizziness","longName":"5734015","preferredDefinition":"A sensation of lightheadedness, unsteadiness, turning, spinning or rocking.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dizziness","conceptCode":"C37943","definition":"A sensation of lightheadedness, unsteadiness, turning, spinning or rocking.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C6B11C0-FAF1-0ECB-E053-F662850AF7A1","latestVersionIndicator":"Yes","beginDate":"2017-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C6B11C0-FB09-0ECB-E053-F662850AF7A1","beginDate":"2017-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-04-05","modifiedBy":"ONEDATA","dateModified":"2017-04-05","deletedIndicator":"No"},{"value":"Autoimmune Toxicity","valueDescription":"Autoimmune Toxicity","ValueMeaning":{"publicId":"5999758","version":"1","preferredName":"Autoimmune Toxicity","longName":"5999758","preferredDefinition":"Pertaining to autoimmunity.: The finding of bodily harm due to the poisonous effects of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autoimmune","conceptCode":"C37916","definition":"Pertaining to autoimmunity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B2373FD-20D1-5610-E053-F662850A9809","latestVersionIndicator":"Yes","beginDate":"2017-10-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B2373FD-20EA-5610-E053-F662850A9809","beginDate":"2017-10-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-09","modifiedBy":"ONEDATA","dateModified":"2017-10-09","deletedIndicator":"No"},{"value":"Depressed level of consciousness","valueDescription":"Depressed Level Of Consciousness","ValueMeaning":{"publicId":"2944340","version":"1","preferredName":"Depressed Level Of Consciousness","longName":"2944340","preferredDefinition":"A neurologic state characterized by decreased ability to perceive and respond.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Depressed Level Of Consciousness","conceptCode":"C78253","definition":"A neurologic state characterized by decreased ability to perceive and respond.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74301D2A-51D2-F34C-E040-BB89AD430317","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B60567A-5134-10FF-E053-F662850A6199","beginDate":"2017-10-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-12","modifiedBy":"ONEDATA","dateModified":"2017-10-12","deletedIndicator":"No"},{"value":"Viral Infection","valueDescription":"Viral Infection","ValueMeaning":{"publicId":"4395770","version":"1","preferredName":"Viral Infection","longName":"4395770","preferredDefinition":"Any disease caused by a virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Viral Infection","conceptCode":"C3439","definition":"Any disease caused by a virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D927-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93742AD9-4AF4-39CE-E053-F662850A16D8","beginDate":"2019-09-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-26","modifiedBy":"ONEDATA","dateModified":"2019-09-26","deletedIndicator":"No"},{"value":"Porphyria cutanea tarda (PCT)","valueDescription":"Porphyria Cutanea Tarda","ValueMeaning":{"publicId":"6944885","version":"1","preferredName":"Porphyria Cutanea Tarda","longName":"6944885","preferredDefinition":"A cutaneous form of the genetic photosensitive disease, porphyria, that is characterized by onset in adult life and the presence of scarring bullae, hyperpigmentation, facial hypertrichosis, and sometimes sclerodermatous thickenings and alopecia.  Uroporphyrins are found in the urine due to a deficiency of uroporphyrinogen decarboxylase, an enzyme required for the synthesis of heme.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Porphyria Cutanea Tarda","conceptCode":"C27725","definition":"A cutaneous form of the genetic photosensitive disease, porphyria, that is characterized by onset in adult life and the presence of scarring bullae, hyperpigmentation, facial hypertrichosis, and sometimes sclerodermatous thickenings and alopecia.  Uroporphyrins are found in the urine due to a deficiency of uroporphyrinogen decarboxylase, an enzyme required for the synthesis of heme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93742AD9-4B02-39CE-E053-F662850A16D8","latestVersionIndicator":"Yes","beginDate":"2019-09-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-26","modifiedBy":"ONEDATA","dateModified":"2019-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93742AD9-4B1B-39CE-E053-F662850A16D8","beginDate":"2019-09-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-26","modifiedBy":"ONEDATA","dateModified":"2019-09-26","deletedIndicator":"No"},{"value":"Acquired iron overload","valueDescription":"Acquired Iron Overload","ValueMeaning":{"publicId":"6944886","version":"1","preferredName":"Acquired Iron Overload","longName":"6944886","preferredDefinition":"Of or relating to a medical condition or characteristic that is not present at birth but develops subsequently.: Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired","conceptCode":"C85869","definition":"Of or relating to a medical condition or characteristic that is not present at birth but develops subsequently.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Iron Overload","conceptCode":"C78393","definition":"Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93742AD9-4B28-39CE-E053-F662850A16D8","latestVersionIndicator":"Yes","beginDate":"2019-09-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-26","modifiedBy":"ONEDATA","dateModified":"2019-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93742AD9-4B41-39CE-E053-F662850A16D8","beginDate":"2019-09-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-26","modifiedBy":"ONEDATA","dateModified":"2019-09-26","deletedIndicator":"No"},{"value":"Pericardial Effusion","valueDescription":"Pericardial Effusion","ValueMeaning":{"publicId":"3227905","version":"1","preferredName":"Pericardial Effusion","longName":"3227905","preferredDefinition":"Fluid collection within the pericardial sac, usually due to inflammation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pericardial Effusion","conceptCode":"C3319","definition":"Fluid collection within the pericardial sac, usually due to inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A0E811F0-F3AC-3136-E040-BB89AD430E1B","latestVersionIndicator":"Yes","beginDate":"2011-04-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-04-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9418104D-F34E-2DFE-E053-F662850A8909","beginDate":"2019-10-04","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-04","modifiedBy":"ONEDATA","dateModified":"2019-10-04","deletedIndicator":"No"},{"value":"Hydrocephalus (pt 15)","valueDescription":"Hydrocephalus","ValueMeaning":{"publicId":"2566172","version":"1","preferredName":"Hydrocephalus","longName":"2566172","preferredDefinition":"A disorder characterized by an abnormal increase of cerebrospinal fluid in the ventricles of the brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hydrocephalus","conceptCode":"C3111","definition":"A disorder characterized by an abnormal increase of cerebrospinal fluid in the ventricles of the brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CF89-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-07-23","endDate":null,"createdBy":"CHANGM","dateCreated":"2003-07-23","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB12E35-951C-7001-E053-F662850A0604","beginDate":"2019-12-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Atypical Meningioma (pt 11)","valueDescription":"Atypical Meningioma","ValueMeaning":{"publicId":"2838613","version":"1","preferredName":"Atypical Meningioma","longName":"2838613","preferredDefinition":"A WHO grade II meningioma with increased mitotic activity or three or more of the following features: increased cellularity, small cells with high nuclear to cytoplasm ratio, prominent nucleoli, uninterrupted patternless or sheet-like growth, and foci of spontaneous or geographic necrosis. (Adapted from WHO 2000.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Meningioma","conceptCode":"C4723","definition":"A WHO grade II meningioma characterized by the presence of brain invasion and an increased mitotic activity, or at least three of the following morphologic features: small cells, high cellularity, prominent nucleoli, lack of architectural pattern, and necrosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A6485A-AF58-B656-E040-BB89AD437D5F","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB12E35-9531-7001-E053-F662850A0604","beginDate":"2019-12-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Meningioma","valueDescription":"Meningioma","ValueMeaning":{"publicId":"4265263","version":"1","preferredName":"Meningioma","longName":"4265263","preferredDefinition":"A generally slow growing tumor attached to the dura mater. It is composed of neoplastic meningothelial (arachnoidal) cells. It typically occurs in adults, often women and it has a wide range of histopathological appearances. Of the various subtypes, meningothelial, fibrous and transitional meningiomas are the most common. Most meningiomas are WHO grade I tumors, and some are WHO grade II or III tumors. Most subtypes share a common clinical behavior, although some subtypes are more likely to recur and follow a more aggressive clinical course. (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Meningioma","conceptCode":"C3230","definition":"A generally slow growing tumor attached to the dura mater. It is composed of neoplastic meningothelial (arachnoidal) cells. It typically occurs in adults, often women and it has a wide range of histopathological appearances. Of the various subtypes, meningothelial, fibrous and transitional meningiomas are the most common. Most meningiomas are WHO grade 1 tumors, and some are WHO grade 2 or 3 tumors. Most subtypes share a common clinical behavior, although some subtypes are more likely to recur and follow a more aggressive clinical course. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4D52-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A32CC08F-F6F8-6CCE-E053-F662850A3248","beginDate":"2020-04-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-04-13","modifiedBy":"ONEDATA","dateModified":"2020-04-13","deletedIndicator":"No"},{"value":"Bowel Incontinence","valueDescription":"Fecal Incontinence","ValueMeaning":{"publicId":"2946549","version":"1","preferredName":"Fecal Incontinence","longName":"2946549","preferredDefinition":"Inability to control the escape of stool from the rectum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fecal Incontinence","conceptCode":"C78498","definition":"Involuntary passage of stool from the rectum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74A40B1A-E7F2-30F2-E040-BB89AD4307C8","latestVersionIndicator":"Yes","beginDate":"2009-09-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-09-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A32CC08F-F6ED-6CCE-E053-F662850A3248","beginDate":"2020-04-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-04-13","modifiedBy":"ONEDATA","dateModified":"2020-04-13","deletedIndicator":"No"},{"value":"Blood factors replacement","valueDescription":"Coagulation Factor Replacement","ValueMeaning":{"publicId":"7590181","version":"1","preferredName":"Coagulation Factor Replacement","longName":"7590181","preferredDefinition":"Factors in the blood that are essential for blood coagulation. The absence or mutation of these factors can lead to hemophilia and blood clotting disorders.: The act of removing one thing and putting another thing in its place.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Coagulation Factor","conceptCode":"C16354","definition":"Factors in the blood that are essential for blood coagulation. The absence or mutation of these factors can lead to hemophilia and blood clotting disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Replacement","conceptCode":"C53610","definition":"The act of removing one thing and putting another thing in its place.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCBE3D85-EA5E-4227-E053-4EBD850A4009","latestVersionIndicator":"Yes","beginDate":"2021-03-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-04","modifiedBy":"ONEDATA","dateModified":"2021-03-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BCBE3D85-EA77-4227-E053-4EBD850A4009","beginDate":"2021-03-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-03-04","modifiedBy":"ONEDATA","dateModified":"2021-03-04","deletedIndicator":"No"},{"value":"Besifloxacin","valueDescription":"Besifloxacin","ValueMeaning":{"publicId":"8012248","version":"1","preferredName":"Besifloxacin","longName":"8012248v1.00","preferredDefinition":"No Value Exists","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Besifloxacin","conceptCode":"C83553","definition":"A synthetic fourth-generation fluoroquinolone antibiotic, with broad spectrum antibacterial activity. Upon administration, besifloxacin targets, binds to and inhibits both bacterial DNA gyrase, an enzyme essential for DNA replication, transcription and repair of bacterial DNA, and bacterial topoisomerase IV, an enzyme required for partitioning of the chromosomal DNA during bacterial cell division. This inhibits DNA replication, transcription, and repair and cell division.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D657015A-0563-72CE-E053-4EBD850AA3FD","latestVersionIndicator":"Yes","beginDate":"2022-01-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2022-01-24","modifiedBy":"CLOHNES","dateModified":"2023-07-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D657015A-057C-72CE-E053-4EBD850AA3FD","beginDate":"2022-01-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2022-01-24","modifiedBy":"ONEDATA","dateModified":"2022-01-24","deletedIndicator":"No"},{"value":"REGEN-COV","valueDescription":"Casirivimab/Imdevimab","ValueMeaning":{"publicId":"8012246","version":"1","preferredName":"Casirivimab/Imdevimab","longName":"8012246","preferredDefinition":"A combination of two monoclonal antibodies, casirivimab and imdevimab, directed against the spike protein (SP) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19. Upon administration, casirivimab and imdevimab specifically target and bind to non-overlapping regions of the receptor-binding domain (RBD) of SP, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2. Binding to two distinct regions of the RBD of SP may decrease the potential for virus escape mutants that occur upon treatment with a single SARS-CoV-2 antibody, and may provide enhanced protection against loss of efficacy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Casirivimab/Imdevimab","conceptCode":"C173743","definition":"A combination of two monoclonal antibodies, casirivimab and imdevimab, directed against the spike protein (SP) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against COVID-19. Upon administration, casirivimab and imdevimab specifically target and bind to non-overlapping regions of the receptor-binding domain (RBD) of SP, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2. Binding to two distinct regions of the RBD of SP may decrease the potential for virus escape mutants that occur upon treatment with a single SARS-CoV-2 antibody, and may provide enhanced protection against loss of efficacy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D657015A-053D-72CE-E053-4EBD850AA3FD","latestVersionIndicator":"Yes","beginDate":"2022-01-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2022-01-24","modifiedBy":"ONEDATA","dateModified":"2022-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D657225B-FAFE-72D0-E053-4EBD850A470D","beginDate":"2022-01-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2022-01-24","modifiedBy":"ONEDATA","dateModified":"2022-01-24","deletedIndicator":"No"},{"value":"Lumbar Puncture","valueDescription":null,"ValueMeaning":{"publicId":"3829087","version":"1","preferredName":"Lumbar Puncture","longName":"3829087v1.00","preferredDefinition":"An invasive procedure in which a hollow needle is introduced through an intervertebral space in the lower back to access the subarachnoid space in order to sample cerebrospinal fluid or to administer medication.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lumbar Puncture","conceptCode":"C15327","definition":"An invasive procedure in which a hollow needle is introduced through an intervertebral space in the lower back to access the subarachnoid space in order to sample cerebrospinal fluid or to administer medication.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2ABB921-528C-6EC3-E040-BB89AD4364F1","latestVersionIndicator":"Yes","beginDate":"2013-07-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-07-29","modifiedBy":"GDEEN","dateModified":"2023-08-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EDFC8325-FA58-3906-E053-731AD00AE0DE","beginDate":"2022-11-21","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-11-21","modifiedBy":"GDEEN","dateModified":"2022-11-21","deletedIndicator":"No"},{"value":"Immunodeficiency","valueDescription":null,"ValueMeaning":{"publicId":"2724511","version":"1","preferredName":"Immunodeficiency Syndrome","longName":"2724511","preferredDefinition":"A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4450987C-2254-3760-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-01-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EFBCA37E-C300-2110-E053-731AD00A2C68","beginDate":"2022-12-13","endDate":null,"createdBy":"GDEEN","dateCreated":"2022-12-13","modifiedBy":"GDEEN","dateModified":"2022-12-13","deletedIndicator":"No"},{"value":"Dysgeusia","valueDescription":null,"ValueMeaning":{"publicId":"2946477","version":"1","preferredName":"Dysgeusia","longName":"2946477","preferredDefinition":"A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dysgeusia","conceptCode":"C28145","definition":"Abnormal sense of taste.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74859E91-C06B-5A7D-E040-BB89AD431CCA","latestVersionIndicator":"Yes","beginDate":"2009-09-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-09-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FC73CB69-063A-25E4-E053-731AD00AA508","beginDate":"2023-05-24","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-05-24","modifiedBy":"GDEEN","dateModified":"2023-05-24","deletedIndicator":"No"},{"value":"Vitamin D Deficiency","valueDescription":null,"ValueMeaning":{"publicId":"14256433","version":"1","preferredName":"Vitamin D Deficiency","longName":"14256433v1.00","preferredDefinition":"Abnormally low level of 25-hydroxyvitamin D in the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vitamin D Deficiency","conceptCode":"C114830","definition":"Abnormally low level of 25-hydroxyvitamin D in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01F90C37-8DDD-337F-E063-731AD00A5373","latestVersionIndicator":"Yes","beginDate":"2023-08-02","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-02","modifiedBy":"GDEEN","dateModified":"2023-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01F90C37-8DE0-337F-E063-731AD00A5373","beginDate":"2023-08-02","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-02","modifiedBy":"GDEEN","dateModified":"2023-08-02","deletedIndicator":"No"},{"value":"Vitamin B12 Deficiency","valueDescription":null,"ValueMeaning":{"publicId":"14256434","version":"1","preferredName":"Vitamin B12 Deficiency","longName":"14256434v1.00","preferredDefinition":"Low serum levels of vitamin B12 (cobalamin) due to poor intestinal absorption, decreased dietary intake, or increased physiologic requirement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vitamin B12 Deficiency","conceptCode":"C131684","definition":"Low serum levels of vitamin B12 (cobalamin) due to poor intestinal absorption, decreased dietary intake, or increased physiologic requirement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01F90C37-8DDE-337F-E063-731AD00A5373","latestVersionIndicator":"Yes","beginDate":"2023-08-02","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-02","modifiedBy":"GDEEN","dateModified":"2023-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01F90C37-8DE1-337F-E063-731AD00A5373","beginDate":"2023-08-02","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-02","modifiedBy":"GDEEN","dateModified":"2023-08-02","deletedIndicator":"No"},{"value":"COVID-19","valueDescription":null,"ValueMeaning":{"publicId":"7351146","version":"1","preferredName":"SARS Coronavirus 2 Infection","longName":"7351146v1.00","preferredDefinition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"COVID-19 Infection","conceptCode":"C171133","definition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA4E2765-E69C-6CEB-E053-4EBD850A871D","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"DWARZEL","dateCreated":"2020-07-13","modifiedBy":"GDEEN","dateModified":"2023-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01F90C37-8DE2-337F-E063-731AD00A5373","beginDate":"2023-08-02","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-02","modifiedBy":"GDEEN","dateModified":"2023-08-02","deletedIndicator":"No"},{"value":"Hepatitis B","valueDescription":null,"ValueMeaning":{"publicId":"4761116","version":"1","preferredName":"Hepatitis B Infection","longName":"4761116v1.00","preferredDefinition":"A viral infection caused by the hepatitis B virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Infection","conceptCode":"C3097","definition":"A viral infection caused by the hepatitis B virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12375748-2AE9-8D8D-E050-BB89AD430CF5","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-03-26","modifiedBy":"GDEEN","dateModified":"2023-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01F90C37-8DE3-337F-E063-731AD00A5373","beginDate":"2023-08-02","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-02","modifiedBy":"GDEEN","dateModified":"2023-08-02","deletedIndicator":"No"},{"value":"Acute Lung Injury","valueDescription":null,"ValueMeaning":{"publicId":"14256435","version":"1","preferredName":"Acute Lung Injury","longName":"14256435v1.00","preferredDefinition":"A finding of acute onset of bilateral pulmonary infiltrates by chest radiograph and a PaO2/FiO2 of less than or equal to 300, in the absence of heart failure. The infiltrate may be rich in neutrophils. This syndrome represents a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Lung Injury","conceptCode":"C155766","definition":"A finding of acute onset of bilateral pulmonary infiltrates by chest radiograph and a PaO2/FiO2 of less than or equal to 300, in the absence of heart failure. The infiltrate may be rich in neutrophils. This syndrome represents a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01F90C37-8DDF-337F-E063-731AD00A5373","latestVersionIndicator":"Yes","beginDate":"2023-08-02","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-02","modifiedBy":"GDEEN","dateModified":"2023-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01F90C37-8DE4-337F-E063-731AD00A5373","beginDate":"2023-08-02","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-02","modifiedBy":"GDEEN","dateModified":"2023-08-02","deletedIndicator":"No"},{"value":"Upper Respiratory Infection","valueDescription":null,"ValueMeaning":{"publicId":"2944013","version":"1","preferredName":"Upper Respiratory Tract Infection","longName":"2944013","preferredDefinition":"An infectious process affecting the upper respiratory tract (nose, paranasal sinuses, pharynx, larynx, or trachea). Symptoms include congestion, sneezing, coughing, fever, and sore throat.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Upper Respiratory Tract Infection","conceptCode":"C35650","definition":"An infectious process affecting the upper respiratory tract (nose, paranasal sinuses, pharynx, larynx, or trachea). Symptoms include congestion, sneezing, coughing, fever, and sore throat.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742DD56B-120B-A7E6-E040-BB89AD43063D","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01F90C37-8DE5-337F-E063-731AD00A5373","beginDate":"2023-08-02","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-02","modifiedBy":"GDEEN","dateModified":"2023-08-02","deletedIndicator":"No"},{"value":"Pneumonia","valueDescription":null,"ValueMeaning":{"publicId":"5296758","version":"1","preferredName":"Pneumonia","longName":"5296758","preferredDefinition":"An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pneumonia","conceptCode":"C3333","definition":"An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3565B23F-B158-8338-E050-BB89AD437D10","latestVersionIndicator":"Yes","beginDate":"2016-06-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01F90C37-8DE6-337F-E063-731AD00A5373","beginDate":"2023-08-02","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-02","modifiedBy":"GDEEN","dateModified":"2023-08-02","deletedIndicator":"No"},{"value":"COVID-19 Prevention","valueDescription":null,"ValueMeaning":{"publicId":"14426891","version":"1","preferredName":"COVID-19 Infection Prevention","longName":"14426891v1.00","preferredDefinition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"COVID-19 Infection","conceptCode":"C171133","definition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0323AC70-3135-77AB-E063-731AD00AC9CE","latestVersionIndicator":"Yes","beginDate":"2023-08-17","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-17","modifiedBy":"GDEEN","dateModified":"2023-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0323AC70-3138-77AB-E063-731AD00AC9CE","beginDate":"2023-08-17","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-17","modifiedBy":"GDEEN","dateModified":"2023-08-17","deletedIndicator":"No"},{"value":"HIV PREP","valueDescription":null,"ValueMeaning":{"publicId":"14426892","version":"1","preferredName":"HIV Infection Prevention","longName":"14426892v1.00","preferredDefinition":"An infection caused by the human immunodeficiency virus._Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HIV Infection","conceptCode":"C3108","definition":"An infection caused by the human immunodeficiency virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Preventive Intervention","conceptCode":"C15843","definition":"Therapeutic, nutritional, environmental, social and/or behavioral interventions at the societal, community, organizational or individual levels to reduce, modify or stop the course of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0323AC70-3136-77AB-E063-731AD00AC9CE","latestVersionIndicator":"Yes","beginDate":"2023-08-17","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-17","modifiedBy":"GDEEN","dateModified":"2023-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0323AC70-3139-77AB-E063-731AD00AC9CE","beginDate":"2023-08-17","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-17","modifiedBy":"GDEEN","dateModified":"2023-08-17","deletedIndicator":"No"},{"value":"Catheter Maintenance","valueDescription":null,"ValueMeaning":{"publicId":"14426893","version":"1","preferredName":"Catheter Maintenance","longName":"14426893v1.00","preferredDefinition":"A flexible tube designed to transfer fluids into or out of the body._The act of sustaining something in its current form or proper condition; upkeep.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Catheter Device","conceptCode":"C50344","definition":"A flexible tube designed to transfer fluids into or out of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Maintenance","conceptCode":"C53297","definition":"The act of sustaining something in its current form or proper condition; upkeep.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0323AC70-3137-77AB-E063-731AD00AC9CE","latestVersionIndicator":"Yes","beginDate":"2023-08-17","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-17","modifiedBy":"GDEEN","dateModified":"2023-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0323AC70-313A-77AB-E063-731AD00AC9CE","beginDate":"2023-08-17","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-17","modifiedBy":"GDEEN","dateModified":"2023-08-17","deletedIndicator":"No"},{"value":"Overactive Bladder","valueDescription":null,"ValueMeaning":{"publicId":"14426895","version":"1","preferredName":"Overactive Bladder","longName":"14426895v1.00","preferredDefinition":"A urinary voiding disorder that includes urinary urgency, with or without incontinence, nocturia, and urinary frequency.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Overactive Bladder","conceptCode":"C200787","definition":"A urinary voiding disorder that includes urinary urgency, with or without incontinence, nocturia, and urinary frequency.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0323C745-205D-7A80-E063-731AD00A5B59","latestVersionIndicator":"Yes","beginDate":"2023-08-17","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-17","modifiedBy":"GDEEN","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0323C745-205E-7A80-E063-731AD00A5B59","beginDate":"2023-08-17","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-17","modifiedBy":"GDEEN","dateModified":"2023-08-17","deletedIndicator":"No"},{"value":"Infusion-Related Reaction","valueDescription":null,"ValueMeaning":{"publicId":"2945113","version":"1","preferredName":"Infusion-Related Reaction","longName":"2945113","preferredDefinition":"A reaction to the infusion of pharmacological or biological substances. Symptoms may appear within minutes to hours following the infusion and may include pruritus, flushing, swelling, dyspnea, bronchospasm, and hypotension.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infusion-Related Reaction","conceptCode":"C78361","definition":"A reaction to the infusion of pharmacological or biological substances. Symptoms may appear within minutes to hours following the infusion and may include pruritus, flushing, swelling, dyspnea, bronchospasm, and hypotension.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7455393D-DF04-CE7B-E040-BB89AD4334EC","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0555860F-4952-0BA1-E063-731AD00ABDA2","beginDate":"2023-09-14","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-09-14","modifiedBy":"GDEEN","dateModified":"2023-09-14","deletedIndicator":"No"},{"value":"Hyponatremia","valueDescription":null,"ValueMeaning":{"publicId":"4291753","version":"1","preferredName":"Hyponatremia","longName":"4291753","preferredDefinition":"Lower than normal levels of sodium in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyponatremia","conceptCode":"C37976","definition":"Lower than normal levels of sodium in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6341-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0555860F-4953-0BA1-E063-731AD00ABDA2","beginDate":"2023-09-14","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-09-14","modifiedBy":"GDEEN","dateModified":"2023-09-14","deletedIndicator":"No"},{"value":"Hordeolum","valueDescription":null,"ValueMeaning":{"publicId":"14476342","version":"1","preferredName":"Stye","longName":"14476342v1.00","preferredDefinition":"An infection of one or more of the glands surrounding the eye.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stye","conceptCode":"C118722","definition":"An infection of one or more of the glands surrounding the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0555860F-4951-0BA1-E063-731AD00ABDA2","latestVersionIndicator":"Yes","beginDate":"2023-09-14","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-09-14","modifiedBy":"GDEEN","dateModified":"2023-09-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0555860F-4954-0BA1-E063-731AD00ABDA2","beginDate":"2023-09-14","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-09-14","modifiedBy":"GDEEN","dateModified":"2023-09-14","deletedIndicator":"No"},{"value":"Atogepant","valueDescription":null,"ValueMeaning":{"publicId":"14484341","version":"1","preferredName":"Atogepant","longName":"14484341v1.00","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atogepant","conceptCode":"C167018","definition":"No value exists.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05D3E1B2-48DD-0AE1-E063-731AD00A230E","latestVersionIndicator":"Yes","beginDate":"2023-09-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-09-20","modifiedBy":"GDEEN","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"05D3E1B2-48DE-0AE1-E063-731AD00A230E","beginDate":"2023-09-20","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-09-20","modifiedBy":"GDEEN","dateModified":"2023-09-20","deletedIndicator":"No"},{"value":"Drug Overdose","valueDescription":null,"ValueMeaning":{"publicId":"14630956","version":"1","preferredName":"Drug Overdose","longName":"14630956v1.00","preferredDefinition":"The use of a drug for a reason other than which it was intended or in a manner or in quantities other than directed._Exposure to, or intake of, an excessive amount of a substance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Drug Abuse","conceptCode":"C16522","definition":"The use of a drug for a reason other than which it was intended or in a manner or in quantities other than directed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Overdose","conceptCode":"C50873","definition":"Exposure to, or intake of, an excessive amount of a substance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0B4FBB52-914A-7D1D-E063-731AD00A9D5E","latestVersionIndicator":"Yes","beginDate":"2023-11-29","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-11-29","modifiedBy":"GDEEN","dateModified":"2023-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4FBB52-914B-7D1D-E063-731AD00A9D5E","beginDate":"2023-11-29","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-11-29","modifiedBy":"GDEEN","dateModified":"2023-11-29","deletedIndicator":"No"},{"value":"Testosterone Hormone Deficiency","valueDescription":null,"ValueMeaning":{"publicId":"6060122","version":"1","preferredName":"Testosterone deficiency","longName":"6060122","preferredDefinition":"A disorder characterized by low testosterone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testosterone Deficiency, CTCAE","conceptCode":"C143195","definition":"A disorder characterized by low testosterone.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647CB354-47A8-5B01-E053-F662850A549B","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"GDEEN","dateModified":"2023-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0B4FBB52-914C-7D1D-E063-731AD00A9D5E","beginDate":"2023-11-29","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-11-29","modifiedBy":"GDEEN","dateModified":"2023-11-29","deletedIndicator":"No"},{"value":"Tinea Versicolor","valueDescription":null,"ValueMeaning":{"publicId":"14650227","version":"1","preferredName":"Tinea Versicolor","longName":"14650227v1.00","preferredDefinition":"A skin condition characterized by hypopigmented, pink or tan, confetti-like, discrete and confluent scaly macules distributed on the chest, shoulders and upper back.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tinea Versicolor","conceptCode":"C112833","definition":"A skin condition characterized by hypopigmented, pink or tan, confetti-like, discrete and confluent scaly macules distributed on the chest, shoulders and upper back.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0BF0EBFB-082D-416A-E063-731AD00A770E","latestVersionIndicator":"Yes","beginDate":"2023-12-07","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-07","modifiedBy":"GDEEN","dateModified":"2023-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0BF0EBFB-082E-416A-E063-731AD00A770E","beginDate":"2023-12-07","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-07","modifiedBy":"GDEEN","dateModified":"2023-12-07","deletedIndicator":"No"},{"value":"Hypertriglyceridemia","valueDescription":null,"ValueMeaning":{"publicId":"4291749","version":"1","preferredName":"Hypertriglyceridemia","longName":"4291749","preferredDefinition":"A laboratory test result indicating elevated triglyceride concentration in the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertriglyceridemia","conceptCode":"C37971","definition":"A laboratory test result indicating elevated triglyceride concentration in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-62B6-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0BF0EBFB-082F-416A-E063-731AD00A770E","beginDate":"2023-12-07","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-07","modifiedBy":"GDEEN","dateModified":"2023-12-07","deletedIndicator":"No"},{"value":"Acne","valueDescription":null,"ValueMeaning":{"publicId":"3055811","version":"1","preferredName":"Acne","longName":"3055811","preferredDefinition":"A disorder of the skin marked by inflammation of oil glands and hair glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acne","conceptCode":"C27195","definition":"An inflammatory process of the sebaceous glands which is characterized by comedones, nodules, papules and/or pustules on the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83AA5DE5-186C-08BE-E040-BB89AD436888","latestVersionIndicator":"Yes","beginDate":"2010-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0BF0EBFB-0830-416A-E063-731AD00A770E","beginDate":"2023-12-07","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-07","modifiedBy":"GDEEN","dateModified":"2023-12-07","deletedIndicator":"No"},{"value":"Primary Effusion Lymphoma","valueDescription":null,"ValueMeaning":{"publicId":"2838711","version":"1","preferredName":"Primary Effusion Lymphoma","longName":"2838711","preferredDefinition":"An aggressive non-Hodgkin B-cell lymphoma composed of large cells, presenting as a serous effusion without detectable tumor masses.  It is universally associated with human herpes virus 8 (HHV-8)/Kaposi sarcoma herpes virus (KSHV) [HHV-8/KSHV].  It mostly occurs in the setting of immunodeficiency; most cases have been reported in HIV positive patients.  The most common sites of involvement are the pleural, pericardial, and peritoneal cavities.  The prognosis is extremely unfavorable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Effusion Lymphoma","conceptCode":"C6915","definition":"A large B-cell lymphoma usually presenting as a serous effusion without detectable tumor masses. It is universally associated with human herpes virus 8 (HHV8), also called Kaposi sarcoma-associated herpesvirus.  It mostly occurs in the setting of immunodeficiency. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. Rare HHV8-positive lymphomas indistinguishable from primary effusion lymphomas (PEL) present as solid tumor masses, and have been termed extracavitary PEL. The prognosis is extremely unfavorable. (WHO 2017)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A7EC44-0A6F-AA83-E040-BB89AD437747","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"COOPERM","dateModified":"2017-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0BF0EBFB-0831-416A-E063-731AD00A770E","beginDate":"2023-12-07","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-07","modifiedBy":"GDEEN","dateModified":"2023-12-07","deletedIndicator":"No"},{"value":"Adrenal Insufficiency","valueDescription":null,"ValueMeaning":{"publicId":"5621717","version":"1","preferredName":"Adrenocortical Insufficiency","longName":"5621717","preferredDefinition":"An endocrine or hormonal disorder that occurs when the adrenal cortex does not produce enough of the hormone cortisol and in some cases, the hormone aldosterone. It may be due to a disorder of the adrenal cortex (Addison's disease or primary adrenal insufficiency) or to inadequate secretion of ACTH by the pituitary gland (secondary adrenal insufficiency).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenocortical Insufficiency","conceptCode":"C26691","definition":"An endocrine or hormonal disorder that occurs when the adrenal cortex does not produce enough of the hormone cortisol and in some cases, the hormone aldosterone. It may be due to a disorder of the adrenal cortex (Addison's disease or primary adrenal insufficiency) or to inadequate secretion of ACTH by the pituitary gland (secondary adrenal insufficiency).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45AE87ED-ED18-6297-E053-F662850A80DB","latestVersionIndicator":"Yes","beginDate":"2017-01-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2017-01-09","modifiedBy":"GDEEN","dateModified":"2023-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0BF0EBFB-0832-416A-E063-731AD00A770E","beginDate":"2023-12-07","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-07","modifiedBy":"GDEEN","dateModified":"2023-12-07","deletedIndicator":"No"},{"value":"Peppermint oil","valueDescription":null,"ValueMeaning":{"publicId":"14666609","version":"1","preferredName":"Peppermint Oil","longName":"14666609v1.00","preferredDefinition":"The essential oil extracted from the leaves of Mentha x piperita. Peppermint oil is used for its aromatic properties and as a flavoring and to treat illnesses of the digestive and respiratory system as well as pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peppermint Oil","conceptCode":"C84045","definition":"The essential oil extracted from the leaves of Mentha x piperita. Peppermint oil is used for its aromatic properties and as a flavoring and to treat illnesses of the digestive and respiratory system as well as pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D1BF159-78AB-39D1-E063-731AD00A38B2","latestVersionIndicator":"Yes","beginDate":"2023-12-22","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-22","modifiedBy":"GDEEN","dateModified":"2023-12-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D1BF159-78AC-39D1-E063-731AD00A38B2","beginDate":"2023-12-22","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-22","modifiedBy":"GDEEN","dateModified":"2023-12-22","deletedIndicator":"No"},{"value":"Gamma-glutamyl Transferase (GGT) increased","valueDescription":null,"ValueMeaning":{"publicId":"2944862","version":"1","preferredName":"Gamma-Glutamyltransferase Increased","longName":"2944862","preferredDefinition":"Increase in the level of the enzyme gamma-glutamyltransferase in the blood, which catalyzes the transfer of a gamma glutamyl group from a gamma glutamyl peptide to another peptide, aminoacids, or water. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gamma-Glutamyltransferase Increased","conceptCode":"C26943","definition":"Increase in the level of the enzyme gamma-glutamyltransferase in the blood, which catalyzes the transfer of a gamma glutamyl group from a gamma glutamyl peptide to another peptide, aminoacids, or water.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7445E0D3-192B-319E-E040-BB89AD434CDB","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D998AA9-EF2C-0993-E063-731AD00ADB3D","beginDate":"2023-12-28","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-28","modifiedBy":"GDEEN","dateModified":"2023-12-28","deletedIndicator":"No"},{"value":"Oligomenorrhea (Irregular menstruation)","valueDescription":null,"ValueMeaning":{"publicId":"14667127","version":"1","preferredName":"Oligomenorrhea","longName":"14667127v1.00","preferredDefinition":"Infrequent menstrual periods.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligomenorrhea","conceptCode":"C113341","definition":"Infrequent menstrual periods.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D998AA9-EF2B-0993-E063-731AD00ADB3D","latestVersionIndicator":"Yes","beginDate":"2023-12-28","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-28","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D998AA9-EF2D-0993-E063-731AD00ADB3D","beginDate":"2023-12-28","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-28","modifiedBy":"GDEEN","dateModified":"2023-12-28","deletedIndicator":"No"},{"value":"Febrile Neutropenia","valueDescription":null,"ValueMeaning":{"publicId":"2946349","version":"1","preferredName":"Neutropenic Fever","longName":"2946349","preferredDefinition":"Neutropenia associated with fever, the latter indicating the presence of an infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Febrile Neutropenia","conceptCode":"C35665","definition":"Neutropenia associated with fever, the latter indicating the presence of an infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746D32D6-F7F5-1467-E040-BB89AD436E21","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0D998AA9-EF2E-0993-E063-731AD00ADB3D","beginDate":"2023-12-28","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-12-28","modifiedBy":"GDEEN","dateModified":"2023-12-28","deletedIndicator":"No"},{"value":"Irregular Menstruation","valueDescription":null,"ValueMeaning":{"publicId":"2945192","version":"1","preferredName":"Irregular Menstruation","longName":"2945192","preferredDefinition":"Deviations from the normal process; e.g. delayed, difficult, profuse, scanty, unusual bleeding, etc.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Irregular Menstruation","conceptCode":"C35219","definition":"Deviations from the normal process; e.g. delayed, difficult, profuse, scanty, unusual bleeding, etc.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"745580E8-424C-8FA9-E040-BB89AD433702","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0DFB5955-CCC6-057D-E063-731AD00A27C0","beginDate":"2024-01-02","endDate":null,"createdBy":"GDEEN","dateCreated":"2024-01-02","modifiedBy":"GDEEN","dateModified":"2024-01-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2737155","version":"1","preferredName":"Concomitant Agent Concomitant Procedure Reason","preferredDefinition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.:Concomitant; following as a consequence.:A particular course of action intended to achieve a result.:An explanation of the cause of some phenomenon or action.","longName":"C70902:C25730:C25218:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Agent","conceptCode":"C70902","definition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol's complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Concomitant","conceptCode":"C25730","definition":"Accessory, accompanying especially in a subordinate or incidental way, occurring or existing during the same period of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Intervention or Procedure","conceptCode":"C25218","definition":"An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49614F69-603C-4D6D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-03-26","modifiedBy":"SBREXT","dateModified":"2008-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FB33-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6921971","version":"1","longName":"CDISC Aligned Collection CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"7318318","version":"1","longName":"Concomitant Medication - CDISC Aligned","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CDISC Aligned NCI Standard Equivalent CDE","type":"CDISC Note","description":"This data element is to be used for CDISC aligned data collection in place of CDE 2003870 from the original NCI Standard CRF Template.","url":null,"context":"NCI Standards"},{"name":"Indication","type":"Preferred Question Text","description":"Indication","url":null,"context":"NCI Standards"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"948370BC-249C-7BEC-E053-F662850A3A98","latestVersionIndicator":"Yes","beginDate":"2019-10-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-10-09","modifiedBy":"GDEEN","dateModified":"2023-02-13","changeDescription":"Created for CDISC aligned NCI Standard CRF task. ghd","administrativeNotes":"02.13.23_Set Reg Status to Standard for all CDISC Aligned content_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}